EPHA6
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A5YKK6 | Y1572 | Sugiyama | CNOT1 CDC39 KIAA1007 NOT1 AD-005 | RMPEQIRLKVGGVDPKQLAVyEEFARNVPGFLPTNDLSQPT |
| A6NEC2 | Y173 | Sugiyama | NPEPPSL1 | NDKMKGFYRSKYTTPSGEVRyAAVTQFEATDARRAFPCWDE |
| A6NHL2 | Y319 | Sugiyama | TUBAL3 | TTACFESSNQLVKCDPRLGKyMACCLLyRGDVVPKEVNAAI |
| A6NMY6 | Y147 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | sLIEIICsRtNQELQEINRVyKEMYKtDLEKDIIsDtsGDF |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00232 | S21 | Sugiyama | PSMD12 | MADGGSERADGRIVKMEVDysATVDQRLPECAKLAKEGRLQ |
| O00264 | T178 | Sugiyama | PGRMC1 HPR6.6 PGRMC | SQFTFKYHHVGKLLKEGEEPtVysDEEEPKDEsARKND___ |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00410 | Y820 | Sugiyama | IPO5 KPNB3 RANBP5 | KLEEHFKNQELRQVKRQDEDyDEQVEEsLQDEDDNDVyILT |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00429 | Y266 | Sugiyama | DNM1L DLP1 DRP1 | NRSQLDINNKKSVTDsIRDEyAFLQKKYPSLANRNGTKYLA |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00469 | Y586 | Sugiyama | PLOD2 | FWFPIFSEKACDELVEEMEHyGKWSGGKHHDsRIsGGyENV |
| O00571 | Y343 | Sugiyama | DDX3X DBX DDX3 | tPGRLVDMMERGKIGLDFCKyLVLDEADRMLDMGFEPQIRR |
| O14579 | Y304 | Sugiyama | COPE | HPFIKEYQAKENDFDRLVLQyAPsA________________ |
| O14602 | Y106 | Sugiyama | EIF1AY | DNKADVILKYNADEARsLKAyGELPEHAKINETDTFGPGDD |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | S912 | Sugiyama | PPP1R12A MBS MYPT1 | TssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTDF |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15173 | Y210 | Sugiyama | PGRMC2 DG6 PMBP | FKEKYDYVGRLLKPGEEPsEytDEEDtKDHNKQD_______ |
| O15371 | Y201 | Sugiyama | EIF3D EIF3S7 | KMRyLEVSEPQDIECCGALEyyDKAFDRITTRSEKPLRSIK |
| O15371 | Y202 | Sugiyama | EIF3D EIF3S7 | MRyLEVSEPQDIECCGALEyyDKAFDRITTRSEKPLRSIKR |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O15372 | Y350 | Sugiyama | EIF3H EIF3S3 | IKEFTAQNLGKLFMAQALQEyNN__________________ |
| O15460 | Y342 | Sugiyama | P4HA2 UNQ290/PRO330 | LLIAPFKEEDEWDSPHIVRYyDVMsDEEIERIKEIAKPKLA |
| O15523 | Y341 | Sugiyama | DDX3Y DBY | tPGRLVDMMERGKIGLDFCKyLVLDEADRMLDMGFEPQIRR |
| O43237 | Y184 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | KIPPEKMRELERKFVKDFQDyMEPEEGCQGsPQRRGPLtsG |
| O43390 | Y296 | Sugiyama | HNRNPR HNRPR | VILYHQPDDKKKNRGFCFLEyEDHKSAAQARRRLMSGKVKV |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y397 | Sugiyama | ACTN4 | GKMVSDINNGWQHLEQAEKGyEEWLLNEIRRLERLDHLAEK |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y727 | Sugiyama | ACTN4 | LEQQHQLIQEALIFDNKHtNytMEHIRVGWEQLLTTIARTI |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43707 | Y886 | Sugiyama | ACTN4 | ELRRELPPDQAEyCIARMAPyQGPDAVPGALDyKsFStALy |
| O43707 | Y898 | Sugiyama | ACTN4 | yCIARMAPyQGPDAVPGALDyKsFStALyGEsDL_______ |
| O43719 | Y353 | Sugiyama | HTATSF1 | DGRWFGGRQITAQAWDGTTDyQVEETSREREERLRGWEAFL |
| O43765 | Y141 | Sugiyama | SGTA SGT SGT1 | NPANAVYFCNRAAAYSKLGNyAGAVQDCERAICIDPAySKA |
| O43765 | Y195 | Sugiyama | SGTA SGT SGT1 | HVEAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTGG |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43837 | Y171 | Sugiyama | IDH3B | YMTRHNNLDLVIIREQtEGEySsLEHESARGVIECLKIVTR |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y129 | Sugiyama | CALU | VERQWKGHDLNEDGLVsWEEyKNATYGYVLDDPDPDDGFNY |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O43865 | Y527 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | LTDDQAKYLGLNKNGPFKPNyYRY_________________ |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60488 | S584 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | CLQIIDRKKDLVKLQAGEyVsLGKVEAALKNCPLIDNICAF |
| O60488 | Y582 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | DGCLQIIDRKKDLVKLQAGEyVsLGKVEAALKNCPLIDNIC |
| O60506 | Y293 | Sugiyama | SYNCRIP HNRPQ NSAP1 | VILyHQPDDKKKNRGFCFLEyEDHKTAAQARRRLMSGKVKV |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60568 | Y444 | Sugiyama | PLOD3 | LWSNFWGALSPDEYYARSEDyVELVQRKRVGVWNVPYISQA |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60716 | Y280 | Sugiyama | CTNND1 KIAA0384 | QPQVRVGGssVDLHRFHPEPyGLEDDQRsMGyDDLDyGMMs |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60927 | S74 | Sugiyama | PPP1R11 HCGV TCTE5 | GRRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGH |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O60934 | Y679 | Sugiyama | NBN NBS NBS1 P95 | FRSLVIKNSTSRNPSGINDDyGQLKNFKKFKKVTYPGAGKL |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75208 | Y93 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | PEssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPA |
| O75223 | Y156 | Sugiyama | GGCT C7orf24 CRF21 | sPQYKKIICMGAKENGLPLEyQEKLKAIEPNDytGKVsEEI |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75347 | Y94 | Sugiyama | TBCA | AyLDLQRILENEKDLEEAEEyKEARLVLDsVKLEA______ |
| O75369 | Y902 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VQFNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLV |
| O75534 | Y597 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | EKVNKtHsVNGItEEADPTIysGKVIRPLRSVDPTQTEYQG |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O95297 | Y263 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | QLDHsGGHHSDKINKSEsVVyADIRKN______________ |
| O95340 | Y182 | Sugiyama | PAPSS2 ATPSK2 | GLYKRARAGEIKGFTGIDsDyEKPEtPERVLKTNLSTVSDC |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95456 | Y287 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | PQSTEILKKLMTTNEIQsNIyt___________________ |
| O95573 | S593 | Sugiyama | ACSL3 ACS3 FACL3 LACS3 | CLKIIDRKKDLVKLQAGEyVsLGKVEAALKNLPLVDNICAY |
| O95573 | Y591 | Sugiyama | ACSL3 ACS3 FACL3 LACS3 | DGCLKIIDRKKDLVKLQAGEyVsLGKVEAALKNLPLVDNIC |
| O95757 | Y30 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | FLNCYIAVARsGGIETIANEySDRCtPACIsLGSRTRAIGN |
| O95834 | Y352 | Sugiyama | EML2 EMAP2 EMAPL2 | EVPEDFGPVRTVAEGHGDtLyVGtTRNSILQGSVHTGFSLL |
| O95861 | Y291 | Sugiyama | BPNT1 | QYHKDVKHMNSAGVLAtLRNyDyyASRVPESIKNALVP___ |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00491 | Y249 | Sugiyama | PNP NP | RHCGLRVFGFSLITNKVIMDyESLEKANHEEVLAAGKQAAQ |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P01893 | Y147 | Sugiyama | HLA-H HLAH | VGPDGPFLRGYEQHAYDGKDyIALNEDLRSWTAADMAAQIT |
| P02545 | Y45 | Sugiyama | LMNA LMN1 | RItRLQEKEDLQELNDRLAVyIDRVRsLETENAGLRLRItE |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04040 | Y447 | Sugiyama | CAT | GEVRRFNtANDDNVtQVRAFyVNVLNEEQRKRLCENIAGHL |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04083 | Y21 | Sugiyama | ANXA1 ANX1 LPC1 | MAMVsEFLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPt |
| P04181 | Y69 | Sugiyama | OAT | KyGAHNyHPLPVALERGKGIyLWDVEGRKYFDFLSSYSAVN |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04818 | Y153 | Sugiyama | TYMS TS OK/SW-cl.29 | PVyGFQWRHFGAEyRDMEsDysGQGVDQLQRVIDTIKtNPD |
| P05187 | Y182 | Sugiyama | ALPP PLAP | GKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQ |
| P05783 | Y363 | Sugiyama | KRT18 CYK18 PIG46 | LHLESELAQTRAEGQRQAQEyEALLNIKVKLEAEIATYRRL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P06493 | Y15 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | ______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKKI |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06737 | Y732 | Sugiyama | PYGL | FGMRIDDVAALDKKGYEAKEyyEALPELKLVIDQIDNGFFS |
| P06737 | Y733 | Sugiyama | PYGL | GMRIDDVAALDKKGYEAKEyyEALPELKLVIDQIDNGFFSP |
| P06737 | Y821 | Sugiyama | PYGL | MVLKNIAASGKFSSDRTIKEyAQNIWNVEPsDLKIsLSNES |
| P06744 | Y351 | Sugiyama | GPI | FGCETHAMLPYDQYLHRFAAyFQQGDMEsNGKYITKSGtRV |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07205 | Y196 | Sugiyama | PGK2 PGKB | MVGVNLPHKASGFLMKKELDyFAKALENPVRPFLAILGGAK |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | Y147 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sLIEIICsRtNQELQEINRVyKEMYKtDLEKDIIsDtsGDF |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07384 | Y42 | Sugiyama | CAPN1 CANPL1 PIG30 | RARELGLGRHENAIKyLGQDyEQLRVRCLQSGTLFRDEAFP |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07686 | Y547 | Sugiyama | HEXB HCC7 | DRLTRHRCRMVERGIAAQPLyAGyCNHENM___________ |
| P07686 | Y550 | Sugiyama | HEXB HCC7 | TRHRCRMVERGIAAQPLyAGyCNHENM______________ |
| P07711 | Y112 | Sugiyama | CTSL CTSL1 | MNGFQNRKPRKGKVFQEPLFyEAPRSVDWREKGyVTPVKNQ |
| P07711 | Y330 | Sugiyama | CTSL CTSL1 | GyVKMAKDRRNHCGIAsAAsyPtV_________________ |
| P07737 | Y129 | Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07741 | Y60 | Sugiyama | APRT | RAAIGLLARHLKATHGGRIDyIAGLDsRGFLFGPSLAQELG |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y754 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | ERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRELKAKKAPK |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07954 | T56 | Sugiyama | FH | FWPPNAARMAsQNSFRIEyDtFGELKVPNDKYYGAQTVRsT |
| P07954 | Y54 | Sugiyama | FH | PSFWPPNAARMAsQNSFRIEyDtFGELKVPNDKYYGAQTVR |
| P08174 | Y224 | Sugiyama | CD55 CR DAF | CLISGSSVQWSDPLPECREIyCPAPPQIDNGIIQGERDHyG |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y430 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KKCLELFsELAEDKENyKKFyEAFSKNLKLGIHEDstNRRR |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | Y129 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | VLtEIIAsRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYY |
| P08758 | Y133 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | IIAsRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRML |
| P08758 | Y91 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | SELTGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLt |
| P08758 | Y94 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | TGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLtEII |
| P08865 | Y156 | Sugiyama | RPSA LAMBR LAMR1 | EAsyVNLPtIALCNTDSPLRyVDIAIPCNNKGAHSVGLMWW |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09874 | Y794 | Sugiyama | PARP1 ADPRT PPOL | AySLLRGGsDDssKDPIDVNyEKLKTDIKVVDRDSEEAEII |
| P09923 | Y179 | Sugiyama | ALPI | GKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQ |
| P09972 | Y358 | Sugiyama | ALDOC ALDC | AAQGKYEGSGEDGGAAAQsLyIANHAY______________ |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG47 | Y59 | Sugiyama | UBB | DQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGMQI |
| P0CG48 | Y59 | Sugiyama | UBC | DQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGMQI |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | Y352 | Sugiyama | LAMC1 LAMB2 | tAEsASECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y431 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | TVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGERAMTK |
| P11142 | Y443 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KQtQtFttysDNQPGVLIQVyEGERAMTKDNNLLGKFELTG |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11310 | Y67 | Sugiyama | ACADM | EFQATARKFAREEIIPVAAEyDKTGEyPVPLIRRAWELGLM |
| P11413 | Y112 | Sugiyama | G6PD | PEEKLKLEDFFARNsyVAGQyDDAAsyQRLNsHMNALHLGs |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P11940 | Y382 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | PLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINPYQP |
| P12004 | Y250 | Sugiyama | PCNA | SADVPLVVEYKIADMGHLKyyLAPKIEDEEGs_________ |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y378 | Sugiyama | ACTN1 | GRMVSDINNAWGCLEQVEKGyEEWLLNEIRRLERLDHLAEK |
| P12814 | Y422 | Sugiyama | ACTN1 | KAsIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEs |
| P12814 | Y708 | Sugiyama | ACTN1 | LEGDHQLIQEALIFDNKHtNytMEHIRVGWEQLLTTIARTI |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | Y373 | Sugiyama | EEF2 EF2 | MITIHLPSPVTAQKyRCELLyEGPPDDEAAMGIKsCDPKGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y565 | Sugiyama | PDIA4 ERP70 ERP72 | DVLIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDA |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13796 | Y462 | Sugiyama | LCP1 PLS2 | VNKPPYPKLGGNMKKLENCNyAVELGKNQAKFsLVGIGGQD |
| P13797 | S122 | Sugiyama | PLS3 | GICALGGTsELssEGtQHsysEEEKyAFVNWINKALENDPD |
| P13797 | T117 | Sugiyama | PLS3 | INRKEGICALGGTsELssEGtQHsysEEEKyAFVNWINKAL |
| P13797 | Y465 | Sugiyama | PLS3 | VNKPPYPKLGANMKKLENCNyAVELGKHPAKFSLVGIGGQD |
| P13798 | Y17 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | ____MERQVLLsEPEEAAALyRGLSRQPALsAACLGPEVtT |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14314 | Y465 | Sugiyama | PRKCSH G19P1 | sLGtWGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLC |
| P14618 | Y370 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NAVLDGADCIMLSGEtAKGDyPLEAVRMQHLIAREAEAAIy |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y429 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IKLYVRRVFITDDFHDMMPKyLNFVKGVVDsDDLPLNVsRE |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14625 | Y677 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDM |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14866 | T282 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | TLKIEYAKPTRLNVFKNDQDtWDyTNPNLsGQGDPGsNPNK |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15374 | Y141 | Sugiyama | UCHL3 | KFLEEsVsMsPEERARyLENyDAIRVtHEtsAHEGQTEAPs |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17812 | Y468 | Sugiyama | CTPS1 CTPS | MRLGKRRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVW |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17844 | Y59 | Sugiyama | DDX5 G17P1 HELR HLR1 | EKLVKKKWNLDELPKFEKNFyQEHPDLARRtAQEVETYRRS |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17980 | Y438 | Sugiyama | PSMC3 TBP1 | EDYMEGILEVQAKKKANLQYyA___________________ |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | S23 | Sugiyama | PGAM1 PGAMA CDABP0006 | AYKLVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQ |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y26 | Sugiyama | PGAM1 PGAMA CDABP0006 | LVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P18754 | Y89 | Sugiyama | RCC1 CHC1 | VVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsVEGSE |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P19387 | Y208 | Sugiyama | POLR2C A-152E5.7 | PDNALRHTVYPKPEEWPKSEySELDEDESQAPYDPNGKPER |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P21980 | T368 | Sugiyama | TGM2 | QPGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKy |
| P21980 | Y583 | Sugiyama | TGM2 | VRALLVEPVINSYLLAERDLyLENPEIKIRILGEPKQKRKL |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y451 | Sugiyama | UBA1 A1S9T UBE1 | CLPEDKEVLTEDKCLQRQNRyDGQVAVFGsDLQEKLGKQKY |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22314 | Y60 | Sugiyama | UBA1 A1S9T UBE1 | GMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSVLVSGL |
| P22314 | Y873 | Sugiyama | UBA1 A1S9T UBE1 | DDSNFHMDFIVAASNLRAENyDIPsADRHKSKLIAGKIIPA |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | Y331 | Sugiyama | HNRNPA2B1 HNRPA2B1 | SNYGPMKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRs |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23193 | Y126 | Sugiyama | TCEA1 GTF2S TFIIS | EsTSsGNVsNRKDETNARDTyVsSFPRAPstsDsVRLKCRE |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23381 | Y212 | Sugiyama | WARS1 IFI53 WARS WRS | VIQMTDDEKYLWKDLtLDQAysyAVENAKDIIACGFDINKT |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23921 | T555 | Sugiyama | RRM1 RR1 | IyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTP |
| P23921 | Y553 | Sugiyama | RRM1 RR1 | EtIyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNV |
| P23921 | Y556 | Sugiyama | RRM1 RR1 | yyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPT |
| P23921 | Y74 | Sugiyama | RRM1 RR1 | VELDTLAAETAATLTTKHPDyAILAARIAVSNLHKETKKVF |
| P24752 | Y188 | Sugiyama | ACAT1 ACAT MAT | TPYGGVKLEDLIVKDGLtDVyNKIHMGsCAENTAKKLNIAR |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24941 | Y15 | Sugiyama | CDK2 CDKN2 | ______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKKI |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25205 | Y456 | Sugiyama | MCM3 | AGIHARLNARCsVLAAANPVyGRyDQyKTPMENIGLQDSLL |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26639 | T629 | Sugiyama | TARS1 TARS | GGKWPFWLSPRQVMVVPVGPtCDEyAQKVRQQFHDAKFMAD |
| P26639 | Y575 | Sugiyama | TARS1 TARS | YHQCATIQLDFQLPIRFNLtyVsHDGDDKKRPVIVHRAILG |
| P26640 | Y601 | Sugiyama | VARS1 G7A VARS VARS2 | VDMDFGTGAVKITPAHDQNDyEVGQRHGLEAIsIMDsRGAL |
| P26885 | Y112 | Sugiyama | FKBP2 FKBP13 | GLLGMCEGEKRKLVIPsELGyGERGAPPKIPGGATLVFEVE |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27708 | Y602 | Sugiyama | CAD | FAHTSQVLVDKSLKGWKEIEyEVVRDAYGNCVTVCNMENLD |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27797 | Y57 | Sugiyama | CALR CRTC | WIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDARFyAL |
| P28062 | Y184 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | GMGLSMGSMICGWDKKGPGLyyVDEHGTRLSGNMFSTGSGN |
| P28062 | Y185 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | MGLSMGSMICGWDKKGPGLyyVDEHGTRLSGNMFSTGSGNT |
| P28066 | Y8 | Sugiyama | PSMA5 | _____________MFLTRsEyDRGVNtFsPEGRLFQVEyAI |
| P28074 | Y171 | Sugiyama | PSMB5 LMPX MB1 X | GMGLSMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGS |
| P29144 | Y1042 | Sugiyama | TPP2 | TEALRDLKIQWMTKLDSsDIyNELKEtyPNyLPLyVARLHQ |
| P29320 | Y736 | Sugiyama | EPHA3 ETK ETK1 HEK TYRO4 | AQFTVIQLVGMLRGIASGMKyLSDMGyVHRDLAARNILINS |
| P29320 | Y742 | Sugiyama | EPHA3 ETK ETK1 HEK TYRO4 | QLVGMLRGIASGMKyLSDMGyVHRDLAARNILINSNLVCKV |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30041 | Y89 | Sugiyama | PRDX6 AOP2 KIAA0106 | IALSIDSVEDHLAWSKDINAyNCEEPtEKLPFPIIDDRNRE |
| P30043 | S202 | Sugiyama | BLVRB FLR SCAN | GHFMLRCLttDEyDGHstyPsHQyQ________________ |
| P30086 | S104 | Sugiyama | PEBP1 PBP PEBP | WHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLV |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y120 | Sugiyama | PEBP1 PBP PEBP | GtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsN |
| P30086 | Y125 | Sugiyama | PEBP1 PBP PEBP | DyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsNRsGDH |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y181 | Sugiyama | PEBP1 PBP PEBP | RAPVAGtCyQAEWDDyVPKLyEQLsGK______________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30520 | Y428 | Sugiyama | ADSS2 ADSS | WNTDISNARAFKELPVNAQNyVRFIEDELQIPVKWIGVGKs |
| P31150 | Y197 | Sugiyama | GDI1 GDIL OPHN2 RABGDIA XAP4 | LGQDVIDFTGHALALYRTDDyLDQPCLETVNRIKLYsEsLA |
| P31153 | Y235 | Sugiyama | MAT2A AMS2 MATA2 | LDEMRDALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGP |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31327 | Y634 | Sugiyama | CPS1 | FAMTNQILVEKSVTGWKEIEyEVVRDADDNCVTVCNMENVD |
| P31939 | Y290 | Sugiyama | ATIC PURH OK/SW-cl.86 | PAGAAVGIPLsEDEAKVCMVyDLyKTLtPIsAAyARARGAD |
| P31939 | Y293 | Sugiyama | ATIC PURH OK/SW-cl.86 | AAVGIPLsEDEAKVCMVyDLyKTLtPIsAAyARARGADRMs |
| P31939 | Y362 | Sugiyama | ATIC PURH OK/SW-cl.86 | IAPGyEEEALTILSKKKNGNyCVLQMDQsYKPDENEVRTLF |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y213 | Sugiyama | YWHAB | LAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtSE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33121 | T695 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | KAKRPELRNYFRSQIDDLyStIKV_________________ |
| P33121 | Y693 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | TMKAKRPELRNYFRSQIDDLyStIKV_______________ |
| P33176 | Y516 | Sugiyama | KIF5B KNS KNS1 | EELAVNyDQKSQEVEDKTKEyELLSDELNQKsATLAsIDAE |
| P33176 | Y62 | Sugiyama | KIF5B KNS KNS1 | ASKPYAFDRVFQSsTsQEQVyNDCAKKIVKDVLEGyNGtIF |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33993 | Y102 | Sugiyama | MCM7 CDC47 MCM2 | QELLPQYKEREVVNKDVLDVyIEHRLMMEQRSRDPGMVRsP |
| P34897 | Y228 | Sugiyama | SHMT2 | QLALTARLFRPRLIIAGTsAyARLIDYARMREVCDEVKAHL |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y336 | Sugiyama | HSPA4 APG2 HSPH2 | RVEPPLRSVLEQTKLKKEDIyAVEIVGGATRIPAVKEKISK |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P34932 | Y660 | Sugiyama | HSPA4 APG2 HSPH2 | VSEDDRNsFtLKLEDTENWLyEDGEDQPKQVYVDKLAELKN |
| P35080 | Y79 | Sugiyama | PFN2 | FFtNGLtLGAKKCSVIRDSLyVDGDCtMDIRTKsQGGEPTy |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35268 | Y114 | Sugiyama | RPL22 | NNLRDWLRVVANSKESYELRyFQINQDEEEEEDED______ |
| P35270 | Y259 | Sugiyama | SPR | QKLLSLLEKDEFKSGAHVDFyDK__________________ |
| P35609 | Y385 | Sugiyama | ACTN2 | GKMVSDIAGAWQRLEQAEKGyEEWLLNEIRRLERLEHLAEK |
| P35609 | Y715 | Sugiyama | ACTN2 | LEGDHQLIQEALVFDNKHtNytMEHIRVGWELLLTTIARTI |
| P36871 | T426 | Sugiyama | PGM1 | KQsVEDILKDHWQKYGRNFFtRyDyEEVEAEGANKMMKDLE |
| P36871 | Y157 | Sugiyama | PGM1 | GPAPEAITDKIFQISKTIEEyAVCPDLKVDLGVLGKQQFDL |
| P36871 | Y430 | Sugiyama | PGM1 | EDILKDHWQKYGRNFFtRyDyEEVEAEGANKMMKDLEALMF |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P36915 | Y599 | Sugiyama | GNL1 HSR1 | EGDEEtPTSAPGSSLAGRNPyALLGEDEC____________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P37837 | Y206 | Sugiyama | TALDO1 TAL TALDO TALDOR | ISPFVGRILDWHVANTDKKSyEPLEDPGVKSVTKIYNYYKK |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P40926 | Y80 | Sugiyama | MDH2 | HtPGVAADLsHIEtKAAVKGyLGPEQLPDCLKGCDVVVIPA |
| P40939 | Y637 | Sugiyama | HADHA HADH | ELLTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILA |
| P40939 | Y639 | Sugiyama | HADHA HADH | LTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILASL |
| P41252 | Y148 | Sugiyama | IARS1 IARS | SAEWKSTVsRLGRWIDFDNDyKTLYPQFMESVWWVFKQLYD |
| P41252 | Y273 | Sugiyama | IARS1 IARS | GRLLILMEARLSALYKLEsDyEILERFPGAYLKGKKYRPLF |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42025 | Y33 | Sugiyama | ACTR1B CTRN2 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALE |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42224 | Y170 | Sugiyama | STAT1 | KDKVMCIEHEIKsLEDLQDEyDFKCKTLQNREHETNGVAKS |
| P43034 | Y137 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | HPVFSVMVSASEDATIKVWDyEtGDFERtLKGHtDsVQDIs |
| P43243 | S206 | Sugiyama | MATR3 KIAA0723 | RDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRD |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43243 | Y219 | Sugiyama | MATR3 KIAA0723 | VLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDsFFGEt |
| P43246 | Y238 | Sugiyama | MSH2 | QRGGILITERKKADFSTKDIyQDLNRLLKGKKGEQMNSAVL |
| P43378 | Y304 | Sugiyama | PTPN9 | HAMTIQELVDYVNARQKQGIyEEyEDIRRENPVGTFHCsMs |
| P43378 | Y307 | Sugiyama | PTPN9 | TIQELVDYVNARQKQGIyEEyEDIRRENPVGTFHCsMsPGN |
| P43490 | Y34 | Sugiyama | NAMPT PBEF PBEF1 | ATDSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKY |
| P46109 | Y15 | Sugiyama | CRKL | ______MSSARFDssDRsAWyMGPVsRQEAQtRLQGQRHGM |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46777 | Y253 | Sugiyama | RPL5 MSTP030 | PDMMEEMyKKAHAAIRENPVyEKKPKKEVKKKRWNRPKMsL |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P47712 | Y456 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | DsDDEsHEPKGtENEDAGsDyQsDNQASWIHRMIMALVSDS |
| P47712 | Y535 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | sFDDDELDAAVADPDEFERIyEPLDVKSKKIHVVDSGLTFN |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47756 | Y64 | Sugiyama | CAPZB | DQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKyDPPLE |
| P47813 | Y106 | Sugiyama | EIF1AX EIF1A EIF4C | DNKADVILKYNADEARsLKAyGELPEHAKINETDTFGPGDD |
| P48637 | S394 | Sugiyama | GSS | LyGEEMVQALKQLKDSEERAsyILMEKIEPEPFENCLLRPG |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49189 | Y360 | Sugiyama | ALDH9A1 ALDH4 ALDH7 ALDH9 | LGFVKVAKEQGAKVLCGGDIyVPEDPKLKDGYYMRPCVLTN |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | S2032 | Sugiyama | FASN FAS | ELDYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEG |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y2454 | Sugiyama | FASN FAS | tPKAKyHGNVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsV |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y277 | Sugiyama | FASN FAS | KEQGVtFPsGDIQEQLIRSLyQsAGVAPEsFEyIEAHGtGT |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49327 | Y959 | Sugiyama | FASN FAS | EASRAFEVSENGNLVVSGKVyQWDDPDPRLFDHPEsPtPNP |
| P49419 | Y88 | Sugiyama | ALDH7A1 ATQ1 | tyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWADIPAP |
| P49588 | Y543 | Sugiyama | AARS1 AARS | QECGVVLDKTCFyAEQGGQIyDEGYLVKVDDssEDKTEFTV |
| P49588 | Y667 | Sugiyama | AARS1 AARS | QQIKKAEEIANEMIEAAKAVyTQDCPLAAAKAIQGLRAVFD |
| P49588 | Y690 | Sugiyama | AARS1 AARS | DCPLAAAKAIQGLRAVFDEtyPDPVRVVSIGVPVSELLDDP |
| P49591 | Y248 | Sugiyama | SARS1 SARS SERS | FMRKEVMQEVAQLsQFDEELyKVIGKGSEKSDDNSYDEKYL |
| P49736 | Y137 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | MRQRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERA |
| P49736 | Y234 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | VFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLPEAPAE |
| P49756 | Y717 | Sugiyama | RBM25 RNPC7 | KFEDEDsDDVPRKRKLVPLDyGEDDKNATKGTVNTEEKRKH |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50395 | Y197 | Sugiyama | GDI2 RABGDIB | LGQDVIDFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLA |
| P50395 | Y203 | Sugiyama | GDI2 RABGDIB | DFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsP |
| P50395 | Y404 | Sugiyama | GDI2 RABGDIB | SDLLVPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRM |
| P50502 | Y213 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | RLLGHWEEAAHDLALACKLDyDEDAsAMLKEVQPRAQKIAE |
| P50542 | Y312 | Sugiyama | PEX5 PXR1 | QAELEEMAKRDAEAHPWLSDyDDLtsATyDKGYQFEEENPL |
| P50897 | S262 | Sugiyama | PPT1 CLN1 PPT | EWFGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVF |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | Y24 | Sugiyama | CCT4 CCTD SRB | NVAPRsGATAGAAGGRGKGAyQDRDKPAQIRFsNISAAKAV |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P50995 | Y482 | Sugiyama | ANXA11 ANX11 | sEtDLLDIRSEYKRMYGKsLyHDISGDtsGDyRKILLKICG |
| P50995 | Y493 | Sugiyama | ANXA11 ANX11 | YKRMYGKsLyHDISGDtsGDyRKILLKICGGND________ |
| P51812 | Y707 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | QYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLA |
| P51813 | Y90 | Sugiyama | BMX | EQtPVERQyPFQIVyKDGLLyVyASNEESRSQWLKALQKEI |
| P51813 | Y92 | Sugiyama | BMX | tPVERQyPFQIVyKDGLLyVyASNEESRSQWLKALQKEIRG |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P52565 | Y144 | Sugiyama | ARHGDIA GDIA1 | SGMKYIQHTyRKGVKIDKtDyMVGsYGPRAEEyEFLtPVEE |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P52788 | Y123 | Sugiyama | SMS | DsTGRVKRLPPIVRGGAIDRyWPTADGRLVEyDIDEVVyDE |
| P52788 | Y336 | Sugiyama | SMS | GNCVNLTEALSLYEEQLGRLyCPVEFSKEIVCVPSYLELWV |
| P52789 | S415 | Sugiyama | HK2 | QRIKENKGEERLRstIGVDGsVyKKHPHFAKRLHKTVRRLV |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P52907 | Y239 | Sugiyama | CAPZA1 | sNEAQtAKEFIKIIENAENEyQTAIsENyQtMSDTTFKALR |
| P52907 | Y247 | Sugiyama | CAPZA1 | EFIKIIENAENEyQTAIsENyQtMSDTTFKALRRQLPVTRT |
| P52948 | Y1215 | Sugiyama | NUP98 ADAR2 | KVHLEKLSLRQRKPDEDMKLyQTPLELKLKHSTVHVDELCP |
| P52948 | Y848 | Sugiyama | NUP98 ADAR2 | PTDKTSRCLIKsPDRLADINyEGRLEAVSRKQGAQFKEyRP |
| P53041 | T121 | Sugiyama | PPP5C PPP5 | RRAASNMALGKFRAALRDyEtVVKVKPHDKDAKMKYQECNK |
| P53611 | Y26 | Sugiyama | RABGGTB GGTB | KDVIIKsDAPDTLLLEKHADyIASYGSKKDDYEYCMSEYLR |
| P53621 | Y391 | Sugiyama | COPA | NPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPEGK |
| P53621 | Y394 | Sugiyama | COPA | ENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPEGKRSS |
| P53621 | Y733 | Sugiyama | COPA | LEKLRKMMKIAEIRKDMsGHyQNALyLGDVSERVRILKNCG |
| P53621 | Y738 | Sugiyama | COPA | KMMKIAEIRKDMsGHyQNALyLGDVSERVRILKNCGQKsLA |
| P53675 | Y921 | Sugiyama | CLTCL1 CLH22 CLTCL CLTD | DSSVVGRYCEKRDPHLACVAyERGQCDLELIKVCNENSLFK |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54577 | S386 | Sugiyama | YARS1 YARS | sRLDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGL |
| P54577 | Y129 | Sugiyama | YARS1 YARS | GVPLEKLKFIKGTDYQLSKEytLDVyRLSSVVTQHDSKKAG |
| P54577 | Y289 | Sugiyama | YARS1 YARS | FPLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDL |
| P54577 | Y292 | Sugiyama | YARS1 YARS | KSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLKNS |
| P54646 | Y179 | Sugiyama | PRKAA2 AMPK AMPK2 | GLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAGPEVDIWS |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P54753 | Y812 | Sugiyama | EPHB3 ETK2 HEK2 TYRO6 | ytssLGGKIPIRWTAPEAIAyRKFTSASDVWSYGIVMWEVM |
| P54756 | Y790 | Sugiyama | EPHA5 BSK EHK1 HEK7 TYRO4 | GQFTVIQLVGMLRGISAGMKyLSDMGyVHRDLAARNILINS |
| P54756 | Y796 | Sugiyama | EPHA5 BSK EHK1 HEK7 TYRO4 | QLVGMLRGISAGMKyLSDMGyVHRDLAARNILINSNLVCKV |
| P54762 | Y798 | Sugiyama | EPHB1 ELK EPHT2 HEK6 NET | yTSSLGGKIPVRWTAPEAIAyRKFTSASDVWSYGIVMWEVM |
| P54764 | Y798 | Sugiyama | EPHA4 HEK8 SEK TYRO1 | AyttRGGKIPIRWTAPEAIAyRKFTSASDVWSYGIVMWEVM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55084 | T359 | Sugiyama | HADHB MSTP029 | DFMYVSQDPKDQLLLGPtYAtPKVLEKAGLTMNDIDAFEFH |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y96 | Sugiyama | NAP1L1 NRP | RRVNALKNLQVKCAQIEAKFyEEVHDLERKyAVLyQPLFDK |
| P55786 | Y173 | Sugiyama | NPEPPS PSA | NDKMKGFYRSKYTTPSGEVRyAAVTQFEATDARRAFPCWDE |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P55809 | Y43 | Sugiyama | OXCT1 OXCT SCOT | TWYKGCVCSFSTSAHRHTKFyTDPVEAVKDIPDGATVLVGG |
| P55884 | Y768 | Sugiyama | EIF3B EIF3S9 | ERRRTMMEDFRKYRKMAQELyMEQKNERLELRGGVDTDELD |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60174 | Y68 | Sugiyama | TPI1 TPI | yIDFARQKLDPKIAVAAQNCyKVTNGAFtGEIsPGMIKDCG |
| P60228 | Y445 | Sugiyama | EIF3E EIF3S6 INT6 | KLNQNSRSEAPNWAtQDsGFy____________________ |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60842 | Y197 | Sugiyama | EIF4A1 DDX2A EIF4A | KMFVLDEADEMLsRGFKDQIyDIFQKLNsNtQVVLLSATMP |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61106 | Y136 | Sugiyama | RAB14 | NTVIILIGNKADLEAQRDVTyEEAKQFAEENGLLFLEASAK |
| P61158 | Y231 | Sugiyama | ACTR3 ARP3 | REVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSK |
| P61158 | Y233 | Sugiyama | ACTR3 ARP3 | VGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKWI |
| P61158 | Y400 | Sugiyama | ACTR3 ARP3 | GGSMLASTPEFYQVCHTKKDyEEIGPsICRHNPVFGVMs__ |
| P61163 | Y241 | Sugiyama | ACTR1A CTRN1 | ACYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPEL |
| P61163 | Y242 | Sugiyama | ACTR1A CTRN1 | CYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPELL |
| P61163 | Y33 | Sugiyama | ACTR1A CTRN1 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALE |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61353 | Y75 | Sugiyama | RPL27 | AAMGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtV |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | T79 | Sugiyama | HSPE1 | EIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDILGK |
| P61604 | Y76 | Sugiyama | HSPE1 | KGGEIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDI |
| P61978 | Y280 | Sugiyama | HNRNPK HNRPK | GFDRMPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRG |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | S215 | Sugiyama | YWHAG | HLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWts |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62191 | Y225 | Sugiyama | PSMC1 | LTHPEyyEEMGIKPPKGVILyGPPGtGKTLLAKAVANQTsA |
| P62191 | Y439 | Sugiyama | PSMC1 | FKKSKENVLyKKQEGtPEGLyL___________________ |
| P62195 | Y148 | Sugiyama | PSMC5 SUG1 | PNKVDPLVSLMMVEKVPDSTyEMIGGLDKQIKEIKEVIELP |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62249 | Y115 | Sugiyama | RPS16 | YYQKYVDEASKKEIKDILIQyDRtLLVADPRRCESKKFGGP |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62333 | Y328 | Sugiyama | PSMC6 SUG2 | ARLDILKIHAGPITKHGEIDyEAIVKLSDGFNGADLRNVCT |
| P62495 | Y345 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | NLDIMRYVLHCQGTEEEKILyLTPEQEKDKSHFTDKETGQE |
| P62714 | Y80 | Sugiyama | PPP2CB | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62805 | Y52 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | KPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIRDAVt |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62847 | Y76 | Sugiyama | RPS24 | FVFGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGL |
| P62847 | Y81 | Sugiyama | RPS24 | RTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYEKKK |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62913 | Y170 | Sugiyama | RPL11 | CIGAKHRISKEEAMRWFQQKyDGIILPGK____________ |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | Y79 | Sugiyama | PPIA CYPA | GFMCQGGDFtRHNGTGGKsIyGEKFEDENFILKHtGPGILs |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P62979 | Y59 | Sugiyama | RPS27A UBA80 UBCEP1 | DQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGAKK |
| P62987 | Y59 | Sugiyama | UBA52 UBCEP2 | DQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGIIE |
| P63092 | Y190 | Sugiyama | GNAS GNAS1 GSP | QLIDCAQYFLDKIDVIKQADyVPSDQDLLRCRVLTSGIFET |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y211 | Sugiyama | YWHAZ | LAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67775 | Y80 | Sugiyama | PPP2CA | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | Y312 | Sugiyama | TUBA1B | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P68366 | Y312 | Sugiyama | TUBA4A TUBA1 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P68400 | Y255 | Sugiyama | CSNK2A1 CK2A1 | GHDNYDQLVRIAKVLGTEDLyDyIDKYNIELDPRFNDILGR |
| P84090 | Y22 | Sugiyama | ERH | sHTILLVQPTKRPEGRtyADyEsVNECMEGVCKMYEEHLKR |
| P84095 | Y40 | Sugiyama | RHOG ARHG | LICYTTNAFPKEyIPTVFDNySAQsAVDGRTVNLNLWDTAG |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00526 | Y15 | Sugiyama | CDK3 CDKN3 | ______MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKKI |
| Q00610 | S1483 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VNEsLNNLFITEEDyQALRTsIDAyDNFDNIsLAQRLEKHE |
| Q00610 | Y1487 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LNNLFITEEDyQALRTsIDAyDNFDNIsLAQRLEKHELIEF |
| Q00610 | Y377 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LAGAEELFARKFNALFAQGNySEAAKVAANAPKGILRtPDt |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00610 | Y921 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | DsRVVGKYCEKRDPHLACVAyERGQCDLELINVCNENSLFK |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01082 | Y556 | Sugiyama | SPTBN1 SPTB2 | EMLYIMDWMDEMKVLVLSQDyGKHLLGVEDLLQKHTLVEAD |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01581 | Y84 | Sugiyama | HMGCS1 HMGCS | DINSLCMTVVQNLMERNNLsyDCIGRLEVGTEtIIDKSKSV |
| Q02809 | Y434 | Sugiyama | PLOD1 LLH PLOD | LWSNFWGALSADGYYARSEDyVDIVQGRRVGVWNVPYISNI |
| Q04206 | Y100 | Sugiyama | RELA NFKB3 | DPPHRPHPHELVGKDCRDGFyEAELCPDRCIHSFQNLGIQC |
| Q04446 | Y200 | Sugiyama | GBE1 | PEHSYEFKHSRPKKPRSLRIyESHVGISSHEGKVASYKHFT |
| Q04446 | Y657 | Sugiyama | GBE1 | RVGTALPGKFKIVLDSDAAEyGGHQRLDHSTDFFSEAFEHN |
| Q04760 | Y136 | PSP | GLO1 | HNGNsDPRGFGHIGIAVPDVySACKRFEELGVKFVKKPDDG |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q06830 | Y34 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | NFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVCPT |
| Q07157 | Y1066 | Sugiyama | TJP1 ZO1 | VEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVPM |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08211 | Y68 | Sugiyama | DHX9 DDX9 LKP NDH2 | MGNSTNKKDAQSNAARDFVNyLVRINEIKsEEVPAFGVAsP |
| Q08752 | Y323 | Sugiyama | PPID CYP40 CYPD | DPSNTKALYRRAQGWQGLKEyDQALADLKKAQGIAPEDKAI |
| Q08830 | Y80 | Sugiyama | FGL1 HFREP1 | VQFLDKGDENTVIDLGSKRQyADCSEIFNDGyKLSGFYKIK |
| Q08J23 | Y51 | Sugiyama | NSUN2 SAKI TRM4 | EAGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALR |
| Q08J23 | Y52 | Sugiyama | NSUN2 SAKI TRM4 | AGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALRE |
| Q09028 | Y154 | Sugiyama | RBBP4 RBAP48 | PQNPCIIATKtPssDVLVFDyTKHPsKPDPsGECNPDLRLR |
| Q12792 | Y309 | Sugiyama | TWF1 PTK9 | MDVIRKIEIDNGDELtADFLyEEVHPKQHAHKQSFAKPKGP |
| Q12874 | Y479 | Sugiyama | SF3A3 SAP61 | WAKLKLQKASERWQPDtEEEyEDssGNVVNKKTYEDLKRQG |
| Q12874 | Y50 | Sugiyama | SF3A3 SAP61 | KSTLRDQINSDHRTRAMQDRyMEVSGNLRDLyDDKDGLRKE |
| Q13043 | Y433 | Sugiyama | STK4 KRS2 MST1 | KsVPGPLKNSsDWKIPQDGDyEFLKsWtVEDLQKRLLALDP |
| Q13098 | Y172 | Sugiyama | GPS1 COPS1 CSN1 | YKGNSIKESIRRGHDDLGDHyLDCGDLSNALKCYSRARDYC |
| Q13123 | Y114 | Sugiyama | IK RED RER | ELAEKYRDRAKERRDGVNKDyEEtELISTTANyRAVGPTAE |
| Q13131 | Y190 | Sugiyama | PRKAA1 AMPK1 | GLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAGPEVDIWS |
| Q13162 | Y188 | Sugiyama | PRDX4 | GLGPIRIPLLSDLTHQISKDyGVyLEDSGHTLRGLFIIDDK |
| Q13162 | Y191 | Sugiyama | PRDX4 | PIRIPLLSDLTHQISKDyGVyLEDSGHTLRGLFIIDDKGIL |
| Q13200 | Y110 | Sugiyama | PSMD2 TRAP2 | TSVPKPLKFLRPHyGKLKEIyENMAPGENKRFAADIISVLA |
| Q13228 | Y43 | Sugiyama | SELENBP1 SBP | REEIVyLPCIyRNtGtEAPDyLATVDVDPKsPQyCQVIHRL |
| Q13228 | Y56 | Sugiyama | SELENBP1 SBP | tGtEAPDyLATVDVDPKsPQyCQVIHRLPMPNLKDELHHSG |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13283 | Y363 | Sugiyama | G3BP1 G3BP | FIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGFV |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13310 | Y238 | Sugiyama | PABPC4 APP1 PABP4 | LSVKVMRDPNGKSKGFGFVSyEKHEDANKAVEEMNGKEISG |
| Q13405 | Y45 | Sugiyama | MRPL49 C11orf4 NOF1 OK/SW-cl.67 | LLSQTQGPPDYPRFVEsVDEyQFVERLLPATRIPDPPKHEH |
| Q13435 | Y591 | Sugiyama | SF3B2 SAP145 | LHDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSD |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13630 | Y316 | Sugiyama | GFUS SDR4E1 TSTA3 | FRFTPFKQAVKETCAWFTDNyEQARK_______________ |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14155 | S518 | Sugiyama | ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 | ERYLLLFPNVLLMLSASPRMsGFIyQGKLPtTGMTITKLED |
| Q14166 | Y508 | Sugiyama | TTLL12 KIAA0153 | YDVFWLRFSNRAFALNDLDDyEKHFTVMNyDPDVVLKQVHC |
| Q14204 | Y2881 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | IDREKAMSRPILYSNWLSKDyIPVDQEELRDyVKARLKVFY |
| Q14204 | Y3379 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | ISDAIREKMKKNYMSNPSYNyEIVNRASLACGPMVKWAIAQ |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | S332 | Sugiyama | CTTN EMS1 | VQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRA |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14432 | Y405 | Sugiyama | PDE3A | LTFQAIHKPRVNPVtsLsENytCsDsEESSEKDKLAIPKRL |
| Q14566 | Y810 | Sugiyama | MCM6 | LTQAGLKGstEGsEsYEEDPyLVVNPNyLLED_________ |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14696 | Y58 | Sugiyama | MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 | PGTPDESTPPPRKKKKDIRDyNDADMARLLEQWEKDDDIEE |
| Q14697 | Y489 | Sugiyama | GANAB G2AN KIAA0088 | PHIKVDSGyRVHEELRNLGLyVKtRDGSDyEGWCWPGSAGY |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q14CX7 | Y19 | Sugiyama | NAA25 C12orf30 MDM20 NAP1 | __MATRGHVQDPNDRRLRPIyDyLDNGNNKMAIQQADKLLK |
| Q14CX7 | Y21 | Sugiyama | NAA25 C12orf30 MDM20 NAP1 | MATRGHVQDPNDRRLRPIyDyLDNGNNKMAIQQADKLLKKH |
| Q15019 | Y211 | Sugiyama | SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2 | ERERLKKRILDEIEEHNIKIyHLPDAEsDEDEDFKEQtRLL |
| Q15052 | S488 | Sugiyama | ARHGEF6 COOL2 KIAA0006 PIXA | ERYLMLFSNVLIMLSASPRMsGFIYQGKIPIAGTVVTRLDE |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15149 | Y3362 | Sugiyama | PLEC PLEC1 | TGLsLLPLSEKAARARQEELySELQAREtFEKTPVEVPVGG |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15691 | Y119 | Sugiyama | MAPRE1 | GKFQDNFEFVQWFKKFFDANyDGKDyDPVAARQGQEtAVAP |
| Q15691 | Y124 | Sugiyama | MAPRE1 | NFEFVQWFKKFFDANyDGKDyDPVAARQGQEtAVAPsLVAP |
| Q15785 | Y25 | Sugiyama | TOMM34 URCC3 | FPDsVEELRAAGNESFRNGQyAEASALyGRALRVLQAQGss |
| Q15785 | Y54 | Sugiyama | TOMM34 URCC3 | RALRVLQAQGssDPEEEsVLysNRAACHLKDGNCRDCIKDC |
| Q15819 | Y143 | Sugiyama | UBE2V2 MMS2 UEV2 | RRLMMSKENMKLPQPPEGQtyNN__________________ |
| Q16181 | Y306 | Sugiyama | SEPTIN7 CDC10 SEPT7 | RNMLIRTHMQDLKDVTNNVHyENyRSRKLAAVtyNGVDNNK |
| Q16204 | Y134 | Sugiyama | CCDC6 D10S170 TST1 | NtLFKKIQALQKEKETLAVNyEKEEEFLTNELSRKLMQLQH |
| Q16513 | T958 | Sugiyama | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q16576 | Y153 | Sugiyama | RBBP7 RBAP46 | PQNPHIIATKtPssDVLVFDyTKHPAKPDPsGECNPDLRLR |
| Q16658 | Y493 | Sugiyama | FSCN1 FAN1 HSN SNL | DHAGVLKASAEtVDPAsLWEy____________________ |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y86 | Sugiyama | KYNU | ENAIYFLGNSLGLQPKMVKtyLEEELDKWAKIAAYGHEVGK |
| Q16762 | Y165 | Sugiyama | TST | PSRPEPAVFKATLDRSLLKTyEQVLENLESKRFQLVDSRSQ |
| Q16763 | Y141 | Sugiyama | UBE2S E2EPF OK/SW-cl.73 | IHPNPESALNEEAGRLLLENyEEyAARARLLtEIHGGAGGP |
| Q16763 | Y144 | Sugiyama | UBE2S E2EPF OK/SW-cl.73 | NPESALNEEAGRLLLENyEEyAARARLLtEIHGGAGGPSGR |
| Q16851 | Y89 | Sugiyama | UGP2 UGP1 | KGPSVDWGKIQRPPEDSIQPyEKIKARGLPDNISsVLNKLV |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q53H82 | Y121 | Sugiyama | LACTB2 CGI-83 | IKKLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLY |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q56P03 | Y106 | Sugiyama | EAPP C14orf11 BM-036 | GsssGNGKVATAPTRyYDDIyFDsDsEDEDRAVQVtKKKKK |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q5JWF2 | Y833 | Sugiyama | GNAS GNAS1 | QLIDCAQYFLDKIDVIKQADyVPSDQDLLRCRVLTSGIFET |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6NVY1 | Y247 | Sugiyama | HIBCH | EDLLALKsPSKENIAsVLENyHtESKIDRDKSFILEEHMDK |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71U36 | Y312 | Sugiyama | TUBA1A TUBA3 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q7RTV0 | Y51 | Sugiyama | PHF5A | VICDSyVRPCTLVRICDECNyGsyQGRCVICGGPGVSDAyy |
| Q86UK7 | Y306 | Sugiyama | ZNF598 | QFSYAPRHSRRNEGVVGGEDyEEVDRysRQGRVARAGTRGA |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86X76 | Y319 | Sugiyama | NIT1 | NyLRQLRRHLPVFQHRRPDLyGNLGHPLS____________ |
| Q86XP3 | Y573 | Sugiyama | DDX42 | VATDVAARGLDIPSIKTVINyDVARDIDTHTHRIGRTGRAG |
| Q86XP3 | Y682 | Sugiyama | DDX42 | ERPGLGSENMDRGNNNVMSNyEAYKPSTGAMGDRLTAMKAA |
| Q8IZP0 | Y23 | Sugiyama | ABI1 SSH3BP1 | ELQMLLEEEIPSGKRALIEsyQNLTRVADyCENNyIQATDK |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N1G4 | Y257 | Sugiyama | LRRC47 KIAA1185 | LRDKRLEKMVSGCQTRSILEyLRVGGRGGGKGKGRAEGSEK |
| Q8NBF2 | Y39 | Sugiyama | NHLRC2 | TSLEYALLDAVTQQEKDSLVyQyLQKVDGWEQDLSVPEFPE |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NFI4 | Y213 | Sugiyama | ST13P5 FAM10A5 | RLLGHWEEAAHDLAFACKLDyDEDAsAMLKEVQPRAQKIAE |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TAQ2 | Y15 | Sugiyama | SMARCC2 BAF170 | ______MAVRKKDGGPNVKYyEAADTVTQFDNVRLWLGKNY |
| Q8TEW0 | Y1080 | Sugiyama | PARD3 PAR3 PAR3A | QERIQAKTREFRERQARERDyAEIQDFHRTFGCDDELMYGG |
| Q8WUA2 | Y401 | Sugiyama | PPIL4 | TSKKHKKKTHHCsEEKEDEDyMPIKNTNQDIYREMGFGHYE |
| Q8WUM4 | Y294 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | IARLQHAAELIKTVASRYDEyVNVKDFSDKINRALAAAKKD |
| Q8WVJ2 | Y145 | Sugiyama | NUDCD2 | ERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK________ |
| Q8WWM7 | Y264 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | ESDMSNGWDPNEMFKFNEENyGVKTtyDssLssytVPLEKD |
| Q8WWM7 | Y270 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | GWDPNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFR |
| Q8WWM7 | Y277 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | FKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRELRAA |
| Q8WX92 | Y541 | Sugiyama | NELFB COBRA1 KIAA1182 | EALQKALEPTGQSGEAVKELysQLGEKLEQLDHRKPsPAQA |
| Q8WX93 | Y1348 | Sugiyama | PALLD KIAA0992 CGI-151 | QWHQQsQstKPKKVRPSASRyAALsDQGLDIKAAFQPEANP |
| Q92598 | Y641 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MIMQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQD |
| Q92598 | Y643 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQDHQ |
| Q92882 | Y207 | Sugiyama | OSTF1 | sLLKKKQGTDAVRtLsNAEDyLDDEDsD_____________ |
| Q92890 | Y261 | Sugiyama | UFD1 UFD1L | GVEPsPsPIKPGDIKRGIPNyEFKLGKITFIRNSRPLVKKV |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96A49 | Y327 | Sugiyama | SYAP1 PRO3113 | AVLEEDsADWEKELQQELQEyEVVtESEKRDENWDKEIEKM |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96AY3 | Y201 | Sugiyama | FKBP10 FKBP65 PSEC0056 | YNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGM |
| Q96AY3 | Y204 | Sugiyama | FKBP10 FKBP65 PSEC0056 | TLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCPG |
| Q96C19 | T84 | Sugiyama | EFHD2 SWS1 | DLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKDMEKMFKQy |
| Q96D46 | Y459 | Sugiyama | NMD3 CGI-07 | YQDFLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRIS |
| Q96G03 | Y177 | Sugiyama | PGM2 MSTP006 | CAGIMItAsHNPKQDNGYKVyWDNGAQIIsPHDKGISQAIE |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96HN2 | Y608 | Sugiyama | AHCYL2 KIAA0828 | LTDEQAKYLGLNKNGPFKPNyYRY_________________ |
| Q96IU4 | S149 | Sugiyama | ABHD14B CIB | PGFVPVAPICTDKINAANyAsVKTPALIVYGDQDPMGQTSF |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96P70 | Y889 | Sugiyama | IPO9 IMP9 KIAA1192 RANBP9 HSPC273 | HGINADDKRLQDIRVKGEEIysMDEGIRTRSKSAKNPERWT |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q99426 | Y98 | Sugiyama | TBCB CG22 CKAP1 | PVDDGCRIHVIDHsGARLGEyEDVSRVEKytIsQEAyDQRQ |
| Q99459 | Y511 | Sugiyama | CDC5L KIAA0432 PCDC5RP | EIVLPENAEKELEEREIDDtyIEDAADVDARKQAIRDAERV |
| Q99459 | Y788 | Sugiyama | CDC5L KIAA0432 PCDC5RP | ECLKEDVQRQQEREKELQHRyADLLLEKETLKSKF______ |
| Q99460 | Y494 | Sugiyama | PSMD1 | RHGGSLGLGLAAMGTARQDVyDLLKTNLYQDDAVTGEAAGL |
| Q99497 | T140 | Sugiyama | PARK7 | GSKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGT |
| Q99497 | Y141 | Sugiyama | PARK7 | SKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGTS |
| Q99536 | Y240 | Sugiyama | VAT1 | TASASKHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIV |
| Q99536 | Y245 | Sugiyama | VAT1 | KHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIVMDPLG |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99613 | Y884 | Sugiyama | EIF3C EIF3S8 | GsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRRGGY |
| Q99733 | Y85 | Sugiyama | NAP1L4 NAP2 | RRINALKQLQVRCAHIEAKFyEEVHDLERKyAALyQPLFDK |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y390 | Sugiyama | ACO2 | KEGWPLDIRVGLIGSCTNssyEDMGRSAAVAKQALAHGLKC |
| Q99798 | Y665 | Sugiyama | ACO2 | DtARYYKKHGIRWVVIGDENyGEGSSREHAALEPRHLGGRA |
| Q99798 | Y71 | Sugiyama | ACO2 | NINIVRKRLNRPLTLSEKIVyGHLDDPAsQEIERGKSYLRL |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q9BQE3 | Y312 | Sugiyama | TUBA1C TUBA6 | TNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRK5 | Y342 | Sugiyama | SDF4 CAB45 PSEC0034 | MIAVADENQNHHLEPEEVLKysEFFTGSKLVDYARsVHEEF |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9BS26 | Y135 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | NGMMMKREYRGQRSVKALADyIRQQKSDPIQEIRDLAEItt |
| Q9BS26 | Y175 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | tLDRSKRNIIGYFEQKDSDNyRVFERVANILHDDCAFLSAF |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BUP3 | Y62 | Sugiyama | HTATIP2 CC3 TIP30 | GLFSKVTLIGRRKLTFDEEAyKNVNQEVVDFEKLDDYASAF |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVP2 | Y548 | Sugiyama | GNL3 E2IG3 NS | RSFILDKIIEEDDAyDFSTDyV___________________ |
| Q9BW91 | Y140 | Sugiyama | NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 | FsPKFNEKDGHVERKSKNGLyEIENGRPRNPAGRTGLVGRG |
| Q9BXS5 | Y418 | Sugiyama | AP1M1 CLTNM | IEKSGYQALPWVRYITQNGDyQLRtQ_______________ |
| Q9BXS6 | Y388 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | LNyEPHKGKLKPWGQSKENNyLNQHVNRINFYKKTYKQPHL |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BZX2 | Y203 | Sugiyama | UCK2 UMPK | SQYITFVKPAFEEFCLPTKKyADVIIPRGADNLVAINLIVQ |
| Q9GZL7 | Y380 | Sugiyama | WDR12 | SGSLDNIVKLWDTRSCKAPLyDLAAHEDKVLSVDWTDTGLL |
| Q9GZT8 | Y175 | Sugiyama | NIF3L1 ALS2CR1 MDS015 My018 | PSKAPNyPTEGNHRVEFNVNytQDLDKVMSAVKGIDGVsVT |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H3G5 | Y199 | Sugiyama | CPVL VLP PSEC0124 UNQ197/PRO223 | LYSALIQFFQIFPEYKNNDFyVTGESyAGKYVPAIAHLIHS |
| Q9H4F8 | Y407 | Sugiyama | SMOC1 | FKRYVKKKAKPKKCARRFtDyCDLNKDKVISLPELKGCLGV |
| Q9H6T3 | Y88 | Sugiyama | RPAP3 | KAKESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKD |
| Q9H6T3 | Y90 | Sugiyama | RPAP3 | KESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKDDs |
| Q9H7Z7 | Y308 | Sugiyama | PTGES2 C9orf15 PGES2 | LISKRLKSRHRLQDNVREDLyEAADKWVAAVGKDRPFMGGQ |
| Q9HA47 | Y205 | Sugiyama | UCK1 URK1 | TQYTTFVKPAFEEFCLPTKKyADVIIPRGVDNMVAINLIVQ |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9HB07 | Y189 | Sugiyama | MYG1 C12orf10 | VEEVDAVDNGISQWAEGEPRyALttTLsARVARLNPTWNHP |
| Q9HB71 | Y165 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | VKTDTVLILCRKKVENTRWDyLtQVEKECKEKEKPsYDtEt |
| Q9NNW7 | Y70 | Sugiyama | TXNRD2 KIAA1652 TRXR2 | GGLACAKEAAQLGRKVAVVDyVEPSPQGTRWGLGGTCVNVG |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NQE9 | Y44 | Sugiyama | HINT3 | TTVssVGTCEAAGKsPEPKDyDstCVFCRIAGRQDPGTELL |
| Q9NQI0 | Y442 | Sugiyama | DDX4 VASA | TPGRLMDIIGKEKIGLKQIKyLVLDEADRMLDMGFGPEMKK |
| Q9NQW7 | Y296 | Sugiyama | XPNPEP1 XPNPEPL XPNPEPL1 | KALCADLsPREKVWVSDKASyAVSETIPKDHRCCMPYTPIC |
| Q9NQW7 | Y588 | Sugiyama | XPNPEP1 XPNPEPL XPNPEPL1 | QTKMIDVDSLTDKECDWLNNyHLtCRDVIGKELQKQGRQEA |
| Q9NRX4 | Y52 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | RSGAPAAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCE |
| Q9NRX4 | Y57 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCECLGGG |
| Q9NSE4 | Y621 | Sugiyama | IARS2 | FDSGTSWSYVLPGPDQRADLyLEGKDQLGGWFQSSLLTSVA |
| Q9NUL3 | Y326 | Sugiyama | STAU2 | MNPISRLAQIQQAKKEKEPDyVLLSERGMPRRREFVMQVKV |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NYU2 | Y1516 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | PMTKEPKLEAAVRIVPEWQDyDQEIKQLQIRFQKEKETGAL |
| Q9NYU2 | Y449 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | IEGLSLHNVLKLNIQPsEADyAVDIRSPAISWVNNLEVDSR |
| Q9NYU2 | Y966 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | LVMKVDALLsAQPKGDPRIEyQFFEDRHSAIKLRPKEGETY |
| Q9NZB2 | Y9 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | ____________MGVQGFQDyIEKHCPsAVVPVELQKLARG |
| Q9UBE0 | S266 | Sugiyama | SAE1 AOS1 SUA1 UBLE1A | LLKFRTDKGRDPSSDTyEEDsELLLQIRNDVLDSLGISPDL |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBS4 | Y89 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | DLGAAyEVLsDSEKRKQyDTyGEEGLKDGHQSSHGDIFSHF |
| Q9UGI8 | Y251 | Sugiyama | TES | RTQYSCYCCKLSMKEGDPAIyAERAGyDKLWHPACFVCSTC |
| Q9UHI6 | Y659 | Sugiyama | DDX20 DP103 GEMIN3 | RVPVLASSsQsGDsEsDSDSySSRTSSQSKGNKsyLEGssD |
| Q9UHX1 | Y269 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | FGKIKSCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNL |
| Q9UHX1 | Y274 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | SCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNLFDLGG |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UK59 | Y533 | Sugiyama | DBR1 | LsDEHEPEQRKKIKRRNQAIyAAVDDDDDDAA_________ |
| Q9UKF6 | Y677 | Sugiyama | CPSF3 CPSF73 | EGsEDDESLREMVELAAQRLyEALtPVH_____________ |
| Q9UKS6 | T209 | Sugiyama | PACSIN3 | QERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQAFE |
| Q9UKS6 | Y206 | Sugiyama | PACSIN3 | RKLQERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQ |
| Q9UKV3 | Y1086 | Sugiyama | ACIN1 ACINUS KIAA0670 | RTALHGVKWPQSNPKFLCADyAEQDELDyHRGLLVDRPsEt |
| Q9UN86 | Y19 | Sugiyama | G3BP2 KIAA0660 | __MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSS |
| Q9UN86 | Y20 | Sugiyama | G3BP2 KIAA0660 | _MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSSY |
| Q9UNF0 | Y267 | Sugiyama | PACSIN2 | VLLEVQKHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFR |
| Q9UPQ0 | S177 | Sugiyama | LIMCH1 KIAA1102 | LAQMRKDTDDIEsPKRSIRDsGyIDCWDsERsDsLsPPRHG |
| Q9UPQ0 | Y179 | Sugiyama | LIMCH1 KIAA1102 | QMRKDTDDIEsPKRSIRDsGyIDCWDsERsDsLsPPRHGRD |
| Q9UPR0 | T584 | Sugiyama | PLCL2 KIAA1092 PLCE2 | KILIKAKKLsSNCSGVEGDVtDEDEGAEMSQRMGKENMEQP |
| Q9UQ80 | Y98 | Sugiyama | PA2G4 EBP1 | TSISVNNCVCHFsPLKSDQDyILKEGDLVKIDLGVHVDGFI |
| Q9Y230 | Y446 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | IKRVysLFLDEsRSTQYMKEyQDAFLFNELKGEtMDTS___ |
| Q9Y262 | S249 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | NVLHSLVDKSNINRQLEVytsGGDPEsVAGEyGRHSLYKML |
| Q9Y262 | Y247 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | VLNVLHSLVDKSNINRQLEVytsGGDPEsVAGEyGRHSLYK |
| Q9Y262 | Y409 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | QLREKYGDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYD |
| Q9Y262 | Y415 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | GDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYDNVHPNY |
| Q9Y262 | Y45 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | MHTGDPKQDLAyERQyEQQtyQVIPEVIKNFIQYFHKTVSD |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3F4 | Y252 | Sugiyama | STRAP MAWD UNRIP | HPEKEFLVAGGEDFKLyKyDyNsGEELEsyKGHFGPIHCVR |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y490 | Y127 | Sugiyama | TLN1 KIAA1027 TLN | TVTDMLMTICARIGITNHDEysLVRELMEEKKEEItGtLRK |
| Q9Y4L1 | Y759 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | AANsLEAFIFEtQDKLyQPEyQEVsTEEQREEISGKLSAAS |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5X3 | Y319 | Sugiyama | SNX5 | MLNIEAAKDLLYRRTKALIDyENSNKALDKARLKSKDVKLA |
| Q9Y617 | Y101 | Sugiyama | PSAT1 PSA | GQFSAVPLNLIGLKAGRCADyVVTGAWSAKAAEEAKKFGTI |
| Q9Y617 | Y70 | Sugiyama | PSAT1 PSA | AKIINNTENLVRELLAVPDNyKVIFLQGGGCGQFSAVPLNL |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| GPVI-mediated activation cascade | R-HSA-114604 | 4.014055e-08 | 7.396 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.937087e-07 | 6.532 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.074783e-05 | 4.969 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.432798e-06 | 5.025 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.432798e-06 | 5.025 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.047507e-05 | 4.516 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.008663e-05 | 4.221 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.097386e-04 | 3.960 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.169970e-04 | 3.932 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 1.804898e-04 | 3.744 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.913326e-04 | 3.718 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.030492e-04 | 3.692 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.756212e-04 | 3.755 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.565292e-04 | 3.591 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.983007e-04 | 3.525 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.599019e-04 | 3.252 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.830425e-04 | 3.166 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.372061e-04 | 3.196 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.962957e-04 | 3.157 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.830169e-04 | 3.106 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 9.652120e-04 | 3.015 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 9.781795e-04 | 3.010 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.016473e-03 | 2.993 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.098506e-03 | 2.959 | 1 | 1 |
| Signaling by PTK6 | R-HSA-8848021 | 1.310767e-03 | 2.882 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.310767e-03 | 2.882 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.465600e-03 | 2.834 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.167691e-03 | 2.664 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.092675e-03 | 2.679 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.092675e-03 | 2.679 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.092675e-03 | 2.679 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.041546e-03 | 2.690 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.041546e-03 | 2.690 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.201888e-03 | 2.657 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.967978e-03 | 2.706 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.897261e-03 | 2.722 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.548233e-03 | 2.594 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.609324e-03 | 2.583 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 2.903075e-03 | 2.537 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.930263e-03 | 2.533 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 3.517011e-03 | 2.454 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.908172e-03 | 2.408 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.292390e-03 | 2.276 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.773226e-03 | 2.239 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.374689e-03 | 2.196 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.934788e-03 | 2.159 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.934788e-03 | 2.159 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 8.192990e-03 | 2.087 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.482486e-03 | 2.023 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.508754e-03 | 2.022 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.545564e-03 | 2.020 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.877340e-03 | 2.005 | 0 | 0 |
| Defective F9 secretion | R-HSA-9673218 | 1.111614e-02 | 1.954 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.250160e-02 | 1.903 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.164568e-02 | 1.934 | 1 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.206640e-02 | 1.918 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.206640e-02 | 1.918 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 1.302449e-02 | 1.885 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.414741e-02 | 1.849 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.639882e-02 | 1.785 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.531851e-02 | 1.815 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.518122e-02 | 1.819 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.652762e-02 | 1.782 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.764728e-02 | 1.753 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.952055e-02 | 1.710 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.952055e-02 | 1.710 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.952055e-02 | 1.710 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.864845e-02 | 1.729 | 1 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.139551e-02 | 1.670 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 2.210940e-02 | 1.655 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.210940e-02 | 1.655 | 0 | 0 |
| Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) | R-HSA-5619110 | 2.210940e-02 | 1.655 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.350372e-02 | 1.629 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.435957e-02 | 1.613 | 1 | 1 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.339576e-02 | 1.631 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.550768e-02 | 1.593 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.560969e-02 | 1.592 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.004083e-02 | 1.522 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.778935e-02 | 1.556 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.778935e-02 | 1.556 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 2.788995e-02 | 1.555 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.931686e-02 | 1.533 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.236228e-02 | 1.490 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.373262e-02 | 1.359 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.373262e-02 | 1.359 | 0 | 0 |
| Defective factor IX causes thrombophilia | R-HSA-9672383 | 4.373262e-02 | 1.359 | 0 | 0 |
| Defective cofactor function of FVIIIa variant | R-HSA-9672396 | 4.373262e-02 | 1.359 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.373262e-02 | 1.359 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.373262e-02 | 1.359 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.373262e-02 | 1.359 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.373262e-02 | 1.359 | 0 | 0 |
| Defective F9 variant does not activate FX | R-HSA-9673202 | 4.373262e-02 | 1.359 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.373262e-02 | 1.359 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.373262e-02 | 1.359 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.373262e-02 | 1.359 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.373262e-02 | 1.359 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.373262e-02 | 1.359 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.231193e-02 | 1.374 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.720786e-02 | 1.429 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.348518e-02 | 1.362 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.150471e-02 | 1.382 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.373262e-02 | 1.359 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.150471e-02 | 1.382 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.572097e-02 | 1.447 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.624273e-02 | 1.441 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.584268e-02 | 1.446 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.301995e-02 | 1.366 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.475188e-02 | 1.459 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.720786e-02 | 1.429 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 4.495662e-02 | 1.347 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.324141e-02 | 1.274 | 1 | 1 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.042298e-02 | 1.297 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.324141e-02 | 1.274 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.495662e-02 | 1.347 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.042298e-02 | 1.297 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.613260e-02 | 1.336 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.362282e-02 | 1.271 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.362282e-02 | 1.271 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.324141e-02 | 1.274 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.803786e-02 | 1.318 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.324141e-02 | 1.274 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.835494e-02 | 1.316 | 1 | 0 |
| Autophagy | R-HSA-9612973 | 4.687401e-02 | 1.329 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.042298e-02 | 1.297 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.436525e-02 | 1.265 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.436525e-02 | 1.265 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.436525e-02 | 1.265 | 0 | 0 |
| Defective gamma-carboxylation of F9 | R-HSA-9673240 | 5.436525e-02 | 1.265 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.436525e-02 | 1.265 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 6.488031e-02 | 1.188 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 6.488031e-02 | 1.188 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 6.488031e-02 | 1.188 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.488031e-02 | 1.188 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.488031e-02 | 1.188 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.904088e-02 | 1.229 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.201886e-02 | 1.207 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.201886e-02 | 1.207 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.488031e-02 | 1.188 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.488031e-02 | 1.188 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.598557e-02 | 1.181 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.504699e-02 | 1.187 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.488031e-02 | 1.188 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.124786e-02 | 1.147 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 6.488031e-02 | 1.188 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.766086e-02 | 1.239 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.562377e-02 | 1.183 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 6.488031e-02 | 1.188 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.329430e-02 | 1.199 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.862952e-02 | 1.163 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.201886e-02 | 1.207 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.812380e-02 | 1.167 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.198214e-02 | 1.143 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.527909e-02 | 1.123 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 7.527909e-02 | 1.123 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.527909e-02 | 1.123 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.527909e-02 | 1.123 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 7.527909e-02 | 1.123 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 7.527909e-02 | 1.123 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.556286e-02 | 1.068 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 8.556286e-02 | 1.068 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.573290e-02 | 1.019 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.057905e-01 | 0.976 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.157368e-01 | 0.937 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.255730e-01 | 0.901 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 1.353005e-01 | 0.869 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.449203e-01 | 0.839 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.544338e-01 | 0.811 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.638419e-01 | 0.786 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.731459e-01 | 0.762 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.823470e-01 | 0.739 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.914463e-01 | 0.718 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 1.914463e-01 | 0.718 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 1.914463e-01 | 0.718 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.004449e-01 | 0.698 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.004449e-01 | 0.698 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.181443e-01 | 0.661 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.090674e-02 | 1.041 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.268473e-01 | 0.644 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.354540e-01 | 0.628 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.354540e-01 | 0.628 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.047874e-01 | 0.980 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.047874e-01 | 0.980 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.047874e-01 | 0.980 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.439654e-01 | 0.613 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.119304e-01 | 0.951 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.523826e-01 | 0.598 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.523826e-01 | 0.598 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.191963e-01 | 0.924 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.607066e-01 | 0.584 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.689384e-01 | 0.570 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.770791e-01 | 0.557 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.770791e-01 | 0.557 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.531828e-01 | 0.815 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.609745e-01 | 0.793 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.009641e-01 | 0.521 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 1.927828e-01 | 0.715 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.164355e-01 | 0.665 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.425038e-01 | 0.615 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.089818e-01 | 0.680 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.523826e-01 | 0.598 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.523826e-01 | 0.598 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.181443e-01 | 0.661 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.181443e-01 | 0.661 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.431173e-01 | 0.844 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.009641e-01 | 0.521 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.582156e-01 | 0.588 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.731459e-01 | 0.762 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.057905e-01 | 0.976 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.354540e-01 | 0.628 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.439654e-01 | 0.613 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.689384e-01 | 0.570 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.930909e-01 | 0.533 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.752810e-02 | 1.058 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.648974e-01 | 0.783 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.638419e-01 | 0.786 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.870702e-01 | 0.542 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.255730e-01 | 0.901 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.353005e-01 | 0.869 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.449203e-01 | 0.839 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.268473e-01 | 0.644 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.607066e-01 | 0.584 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.689384e-01 | 0.570 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.930909e-01 | 0.533 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.009641e-01 | 0.521 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.527909e-02 | 1.123 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.157368e-01 | 0.937 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.093438e-01 | 0.679 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.638419e-01 | 0.786 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.638419e-01 | 0.786 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.439654e-01 | 0.613 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.093438e-01 | 0.679 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.181443e-01 | 0.661 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.335178e-01 | 0.632 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.660122e-01 | 0.575 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.439961e-01 | 0.613 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.255730e-01 | 0.901 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.157368e-01 | 0.937 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 9.573290e-02 | 1.019 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 9.573290e-02 | 1.019 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 1.544338e-01 | 0.811 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.777630e-02 | 1.010 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.777630e-02 | 1.010 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.544338e-01 | 0.811 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.439654e-01 | 0.613 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.607066e-01 | 0.584 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.607066e-01 | 0.584 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.527909e-02 | 1.123 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 8.556286e-02 | 1.068 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 8.556286e-02 | 1.068 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.157368e-01 | 0.937 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.544338e-01 | 0.811 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.638419e-01 | 0.786 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.638419e-01 | 0.786 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.731459e-01 | 0.762 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.914463e-01 | 0.718 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.004449e-01 | 0.698 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.093438e-01 | 0.679 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.181443e-01 | 0.661 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.354540e-01 | 0.628 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.607066e-01 | 0.584 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.689384e-01 | 0.570 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.689384e-01 | 0.570 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.416439e-01 | 0.849 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.851296e-01 | 0.545 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.338927e-01 | 0.873 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.130542e-01 | 0.672 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.718355e-02 | 1.012 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.823470e-01 | 0.739 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.638419e-01 | 0.786 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.004449e-01 | 0.698 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.004449e-01 | 0.698 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.582156e-01 | 0.588 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 1.731459e-01 | 0.762 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.823470e-01 | 0.739 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.689384e-01 | 0.570 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.731459e-01 | 0.762 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.930909e-01 | 0.533 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.731459e-01 | 0.762 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.914463e-01 | 0.718 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.930909e-01 | 0.533 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.268473e-01 | 0.644 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.057905e-01 | 0.976 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.449203e-01 | 0.839 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 2.093438e-01 | 0.679 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.093438e-01 | 0.679 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.093438e-01 | 0.679 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 2.354540e-01 | 0.628 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.228725e-01 | 0.911 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 2.770791e-01 | 0.557 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.851296e-01 | 0.545 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.930909e-01 | 0.533 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.688371e-01 | 0.773 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.927828e-01 | 0.715 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.989772e-01 | 0.524 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.962058e-01 | 0.528 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.335178e-01 | 0.632 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.573290e-02 | 1.019 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.181443e-01 | 0.661 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.439654e-01 | 0.613 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 1.378410e-01 | 0.861 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.268473e-01 | 0.644 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.004449e-01 | 0.698 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 2.354540e-01 | 0.628 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.157368e-01 | 0.937 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.255730e-01 | 0.901 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.544338e-01 | 0.811 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.638419e-01 | 0.786 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.004449e-01 | 0.698 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.354540e-01 | 0.628 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.689384e-01 | 0.570 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.770791e-01 | 0.557 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 2.523826e-01 | 0.598 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.243415e-01 | 0.905 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.527909e-02 | 1.123 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.556286e-02 | 1.068 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.573290e-02 | 1.019 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.353005e-01 | 0.869 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.268473e-01 | 0.644 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.727928e-01 | 0.762 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.191963e-01 | 0.924 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.415305e-01 | 0.849 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.914463e-01 | 0.718 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.851296e-01 | 0.545 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.057905e-01 | 0.976 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.255730e-01 | 0.901 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.004449e-01 | 0.698 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.451134e-01 | 0.611 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.882676e-01 | 0.725 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.376264e-01 | 0.624 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.766302e-01 | 0.558 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.189756e-01 | 0.925 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.157368e-01 | 0.937 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.353005e-01 | 0.869 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.752810e-02 | 1.058 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.482636e-01 | 0.829 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.454691e-01 | 0.837 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 9.573290e-02 | 1.019 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.607066e-01 | 0.584 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.155486e-01 | 0.937 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.523826e-01 | 0.598 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.340614e-01 | 0.873 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.766856e-01 | 0.558 | 0 | 0 |
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | R-HSA-159763 | 9.573290e-02 | 1.019 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 1.057905e-01 | 0.976 | 0 | 0 |
| Gamma-carboxylation of protein precursors | R-HSA-159740 | 1.544338e-01 | 0.811 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 1.638419e-01 | 0.786 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.731459e-01 | 0.762 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.523826e-01 | 0.598 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.445223e-01 | 0.840 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.191963e-01 | 0.924 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.467022e-01 | 0.834 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.914463e-01 | 0.718 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.439654e-01 | 0.613 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.609745e-01 | 0.793 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 3.009641e-01 | 0.521 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.377089e-01 | 0.624 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.023704e-01 | 0.990 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.268473e-01 | 0.644 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.354540e-01 | 0.628 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.770791e-01 | 0.557 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.978647e-01 | 0.704 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 2.004449e-01 | 0.698 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.418857e-02 | 1.075 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 2.607066e-01 | 0.584 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.499730e-01 | 0.602 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.215009e-01 | 0.915 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.840924e-01 | 0.547 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.789368e-01 | 0.747 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.268473e-01 | 0.644 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.354540e-01 | 0.628 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.119304e-01 | 0.951 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.689384e-01 | 0.570 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.294137e-01 | 0.639 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 2.499730e-01 | 0.602 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.847478e-01 | 0.733 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.004449e-01 | 0.698 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.004449e-01 | 0.698 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.847478e-01 | 0.733 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.281850e-01 | 0.892 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.817070e-01 | 0.741 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.089818e-01 | 0.680 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.119304e-01 | 0.951 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.770791e-01 | 0.557 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.788311e-01 | 0.555 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.480833e-01 | 0.605 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.449203e-01 | 0.839 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.449096e-01 | 0.611 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 2.049178e-01 | 0.688 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.171342e-01 | 0.663 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.871170e-01 | 0.542 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.735122e-01 | 0.761 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.228725e-01 | 0.911 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.297896e-01 | 0.887 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.192028e-01 | 0.924 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.648987e-01 | 0.577 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.797697e-01 | 0.553 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.014749e-01 | 0.521 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.035156e-01 | 0.518 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.076176e-01 | 0.512 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.076176e-01 | 0.512 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.076176e-01 | 0.512 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.087501e-01 | 0.510 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.087501e-01 | 0.510 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.087501e-01 | 0.510 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.087501e-01 | 0.510 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 3.087501e-01 | 0.510 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.087501e-01 | 0.510 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.113908e-01 | 0.507 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.158072e-01 | 0.501 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.164498e-01 | 0.500 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.164498e-01 | 0.500 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.164498e-01 | 0.500 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.164498e-01 | 0.500 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.164498e-01 | 0.500 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.164498e-01 | 0.500 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.164498e-01 | 0.500 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.164498e-01 | 0.500 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.164498e-01 | 0.500 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.205150e-01 | 0.494 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.236329e-01 | 0.490 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.240642e-01 | 0.489 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.240642e-01 | 0.489 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.240642e-01 | 0.489 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.240642e-01 | 0.489 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.240642e-01 | 0.489 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.240642e-01 | 0.489 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.240642e-01 | 0.489 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.240642e-01 | 0.489 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.240642e-01 | 0.489 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.266000e-01 | 0.486 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.280503e-01 | 0.484 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.280503e-01 | 0.484 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.315943e-01 | 0.479 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.315943e-01 | 0.479 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.315943e-01 | 0.479 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.315943e-01 | 0.479 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.315943e-01 | 0.479 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.315943e-01 | 0.479 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.315943e-01 | 0.479 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.321188e-01 | 0.479 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.334726e-01 | 0.477 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 3.361804e-01 | 0.473 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.390410e-01 | 0.470 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.390410e-01 | 0.470 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.390410e-01 | 0.470 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.390410e-01 | 0.470 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.442815e-01 | 0.463 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.442815e-01 | 0.463 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.464051e-01 | 0.460 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.464051e-01 | 0.460 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.464051e-01 | 0.460 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.464051e-01 | 0.460 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.536876e-01 | 0.451 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.536876e-01 | 0.451 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.536876e-01 | 0.451 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.536876e-01 | 0.451 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.536876e-01 | 0.451 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 3.536876e-01 | 0.451 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.536876e-01 | 0.451 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.569944e-01 | 0.447 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.603864e-01 | 0.443 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.608895e-01 | 0.443 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.608895e-01 | 0.443 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.608895e-01 | 0.443 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 3.608895e-01 | 0.443 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.630572e-01 | 0.440 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.630572e-01 | 0.440 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.680115e-01 | 0.434 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.680115e-01 | 0.434 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.680115e-01 | 0.434 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.680115e-01 | 0.434 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 3.680115e-01 | 0.434 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.680115e-01 | 0.434 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.680115e-01 | 0.434 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.680115e-01 | 0.434 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.691113e-01 | 0.433 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.750546e-01 | 0.426 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.750546e-01 | 0.426 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.750546e-01 | 0.426 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.750546e-01 | 0.426 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.750546e-01 | 0.426 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 3.750546e-01 | 0.426 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.820197e-01 | 0.418 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.820197e-01 | 0.418 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.820197e-01 | 0.418 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.820197e-01 | 0.418 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 3.820197e-01 | 0.418 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.820197e-01 | 0.418 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.882073e-01 | 0.411 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.882073e-01 | 0.411 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 3.889075e-01 | 0.410 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.889075e-01 | 0.410 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 3.957190e-01 | 0.403 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.957190e-01 | 0.403 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.957842e-01 | 0.403 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 3.960606e-01 | 0.402 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.024550e-01 | 0.395 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.024550e-01 | 0.395 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.077537e-01 | 0.390 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.091163e-01 | 0.388 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.091163e-01 | 0.388 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.091163e-01 | 0.388 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.091163e-01 | 0.388 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.091163e-01 | 0.388 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.091163e-01 | 0.388 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.116273e-01 | 0.385 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.154885e-01 | 0.381 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.157038e-01 | 0.381 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.157038e-01 | 0.381 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.157038e-01 | 0.381 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.157038e-01 | 0.381 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.200502e-01 | 0.377 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.222182e-01 | 0.374 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.222182e-01 | 0.374 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.269958e-01 | 0.370 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.269958e-01 | 0.370 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.286604e-01 | 0.368 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.318542e-01 | 0.365 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.350312e-01 | 0.361 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.350312e-01 | 0.361 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.350312e-01 | 0.361 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.371155e-01 | 0.359 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.383846e-01 | 0.358 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.413313e-01 | 0.355 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.435718e-01 | 0.353 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.475616e-01 | 0.349 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.475616e-01 | 0.349 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.533773e-01 | 0.344 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.533773e-01 | 0.344 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.537227e-01 | 0.343 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.537227e-01 | 0.343 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.537227e-01 | 0.343 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.598155e-01 | 0.337 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.598155e-01 | 0.337 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.598155e-01 | 0.337 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.717992e-01 | 0.326 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.717992e-01 | 0.326 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.717992e-01 | 0.326 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.721571e-01 | 0.326 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.754340e-01 | 0.323 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.762886e-01 | 0.322 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.776915e-01 | 0.321 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.776915e-01 | 0.321 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.892807e-01 | 0.310 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.892807e-01 | 0.310 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.892807e-01 | 0.310 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.892807e-01 | 0.310 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.892807e-01 | 0.310 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.934007e-01 | 0.307 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.949790e-01 | 0.305 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.949790e-01 | 0.305 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.949790e-01 | 0.305 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.949790e-01 | 0.305 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.949790e-01 | 0.305 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.006141e-01 | 0.300 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.006141e-01 | 0.300 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.061867e-01 | 0.296 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.061867e-01 | 0.296 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.061867e-01 | 0.296 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.109765e-01 | 0.292 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.116974e-01 | 0.291 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.116974e-01 | 0.291 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.116974e-01 | 0.291 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.116974e-01 | 0.291 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.171470e-01 | 0.286 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.171470e-01 | 0.286 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.225361e-01 | 0.282 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.225361e-01 | 0.282 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.331355e-01 | 0.273 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.331355e-01 | 0.273 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.331355e-01 | 0.273 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.331355e-01 | 0.273 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.331355e-01 | 0.273 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.331355e-01 | 0.273 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.331355e-01 | 0.273 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.331355e-01 | 0.273 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 5.331355e-01 | 0.273 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.349061e-01 | 0.272 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.383471e-01 | 0.269 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.383471e-01 | 0.269 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 5.383471e-01 | 0.269 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.383471e-01 | 0.269 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.383471e-01 | 0.269 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.383471e-01 | 0.269 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.435009e-01 | 0.265 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.435009e-01 | 0.265 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.435009e-01 | 0.265 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.435009e-01 | 0.265 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.435009e-01 | 0.265 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.485974e-01 | 0.261 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.485974e-01 | 0.261 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.485974e-01 | 0.261 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.493456e-01 | 0.260 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.536374e-01 | 0.257 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.586214e-01 | 0.253 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.586214e-01 | 0.253 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.612629e-01 | 0.251 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.635500e-01 | 0.249 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.635500e-01 | 0.249 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.644821e-01 | 0.248 | 0 | 0 |
| Translation | R-HSA-72766 | 5.673253e-01 | 0.246 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 5.684239e-01 | 0.245 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 5.684239e-01 | 0.245 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.732437e-01 | 0.242 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.732437e-01 | 0.242 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.740383e-01 | 0.241 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.740383e-01 | 0.241 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.771899e-01 | 0.239 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.827233e-01 | 0.235 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.865428e-01 | 0.232 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.873842e-01 | 0.231 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.873842e-01 | 0.231 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.873842e-01 | 0.231 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.873842e-01 | 0.231 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.873842e-01 | 0.231 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.873842e-01 | 0.231 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 5.873842e-01 | 0.231 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 5.919934e-01 | 0.228 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 5.919934e-01 | 0.228 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.951960e-01 | 0.225 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.965514e-01 | 0.224 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.965514e-01 | 0.224 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.965514e-01 | 0.224 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.010587e-01 | 0.221 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.010587e-01 | 0.221 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.055160e-01 | 0.218 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.055160e-01 | 0.218 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.055160e-01 | 0.218 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.055160e-01 | 0.218 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.099237e-01 | 0.215 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.142825e-01 | 0.212 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.145852e-01 | 0.211 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.185928e-01 | 0.209 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.185928e-01 | 0.209 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 6.185928e-01 | 0.209 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.185928e-01 | 0.209 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.217969e-01 | 0.206 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.222453e-01 | 0.206 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.228552e-01 | 0.206 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.270703e-01 | 0.203 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.270703e-01 | 0.203 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.270703e-01 | 0.203 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.312385e-01 | 0.200 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 6.312385e-01 | 0.200 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.353603e-01 | 0.197 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.353603e-01 | 0.197 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.394364e-01 | 0.194 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.434671e-01 | 0.191 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.434671e-01 | 0.191 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.434671e-01 | 0.191 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.445045e-01 | 0.191 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.474530e-01 | 0.189 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.504644e-01 | 0.187 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.513946e-01 | 0.186 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 6.552924e-01 | 0.184 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.552924e-01 | 0.184 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.580028e-01 | 0.182 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.591468e-01 | 0.181 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.612110e-01 | 0.180 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.629584e-01 | 0.179 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.629584e-01 | 0.179 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.629584e-01 | 0.179 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.629584e-01 | 0.179 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.667276e-01 | 0.176 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.690968e-01 | 0.175 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.704548e-01 | 0.174 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.742717e-01 | 0.171 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.777854e-01 | 0.169 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.777854e-01 | 0.169 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.793812e-01 | 0.168 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.813897e-01 | 0.167 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.813897e-01 | 0.167 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.849539e-01 | 0.164 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.849539e-01 | 0.164 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.954102e-01 | 0.158 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.954102e-01 | 0.158 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.988184e-01 | 0.156 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.988184e-01 | 0.156 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.988184e-01 | 0.156 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.988184e-01 | 0.156 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.988184e-01 | 0.156 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.039589e-01 | 0.152 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.088170e-01 | 0.149 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 7.088170e-01 | 0.149 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.088170e-01 | 0.149 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.120760e-01 | 0.147 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.120760e-01 | 0.147 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.152987e-01 | 0.146 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.152987e-01 | 0.146 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.184855e-01 | 0.144 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.216369e-01 | 0.142 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.247531e-01 | 0.140 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.247531e-01 | 0.140 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 7.278347e-01 | 0.138 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.278347e-01 | 0.138 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.278347e-01 | 0.138 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.306261e-01 | 0.136 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.308820e-01 | 0.136 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.342884e-01 | 0.134 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.344467e-01 | 0.134 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.368750e-01 | 0.133 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.368750e-01 | 0.133 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.368750e-01 | 0.133 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.396955e-01 | 0.131 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.398216e-01 | 0.131 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 7.414785e-01 | 0.130 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.421490e-01 | 0.130 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.427354e-01 | 0.129 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.442594e-01 | 0.128 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.512834e-01 | 0.124 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.512834e-01 | 0.124 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.512834e-01 | 0.124 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.525547e-01 | 0.123 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.622430e-01 | 0.118 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.649070e-01 | 0.116 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.701463e-01 | 0.113 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.752694e-01 | 0.111 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.752694e-01 | 0.111 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.765442e-01 | 0.110 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.802790e-01 | 0.108 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 7.816362e-01 | 0.107 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.827420e-01 | 0.106 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.827420e-01 | 0.106 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 7.834648e-01 | 0.106 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.846802e-01 | 0.105 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.875859e-01 | 0.104 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.875859e-01 | 0.104 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.883039e-01 | 0.103 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.888708e-01 | 0.103 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 7.899674e-01 | 0.102 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.923224e-01 | 0.101 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.923224e-01 | 0.101 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.923224e-01 | 0.101 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.946511e-01 | 0.100 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.969538e-01 | 0.099 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 8.014825e-01 | 0.096 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.080879e-01 | 0.093 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.102408e-01 | 0.091 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.102408e-01 | 0.091 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.123697e-01 | 0.090 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.266211e-01 | 0.083 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.266211e-01 | 0.083 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.305006e-01 | 0.081 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.338642e-01 | 0.079 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.361365e-01 | 0.078 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.379764e-01 | 0.077 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 8.397956e-01 | 0.076 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.415946e-01 | 0.075 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.433735e-01 | 0.074 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.433735e-01 | 0.074 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.451325e-01 | 0.073 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.451325e-01 | 0.073 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.519742e-01 | 0.070 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.519742e-01 | 0.070 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.536371e-01 | 0.069 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.536371e-01 | 0.069 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.569075e-01 | 0.067 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.601051e-01 | 0.065 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.601051e-01 | 0.065 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.689016e-01 | 0.061 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.707475e-01 | 0.060 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.707475e-01 | 0.060 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.750583e-01 | 0.058 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.805844e-01 | 0.055 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.805844e-01 | 0.055 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.832556e-01 | 0.054 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.834493e-01 | 0.054 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.845689e-01 | 0.053 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.845689e-01 | 0.053 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.845689e-01 | 0.053 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.933592e-01 | 0.049 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.003618e-01 | 0.046 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.025928e-01 | 0.045 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.058465e-01 | 0.043 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.079554e-01 | 0.042 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.107178e-01 | 0.041 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.128398e-01 | 0.040 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.135985e-01 | 0.039 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.159314e-01 | 0.038 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.168788e-01 | 0.038 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.214588e-01 | 0.036 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.266247e-01 | 0.033 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.266247e-01 | 0.033 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.273005e-01 | 0.033 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.299461e-01 | 0.032 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.310272e-01 | 0.031 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.401809e-01 | 0.027 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.415241e-01 | 0.026 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.418688e-01 | 0.026 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.428373e-01 | 0.026 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.455686e-01 | 0.024 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.490446e-01 | 0.023 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.495248e-01 | 0.022 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.506865e-01 | 0.022 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.517949e-01 | 0.021 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.523399e-01 | 0.021 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.564842e-01 | 0.019 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.593555e-01 | 0.018 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.792559e-01 | 0.009 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.810677e-01 | 0.008 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.909021e-01 | 0.004 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.921632e-01 | 0.003 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.921632e-01 | 0.003 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.934038e-01 | 0.003 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.937723e-01 | 0.003 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.965498e-01 | 0.002 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.990424e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.993165e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.995186e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.554312e-15 | 14.808 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.865175e-14 | 13.729 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.052314e-14 | 13.392 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.211253e-13 | 12.917 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.784128e-13 | 12.749 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.582690e-13 | 12.446 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.582690e-13 | 12.446 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.933831e-13 | 12.307 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.933831e-13 | 12.307 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.674350e-13 | 12.246 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.230394e-13 | 12.035 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.203038e-12 | 11.920 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.211231e-12 | 11.655 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.716605e-12 | 11.566 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.912226e-12 | 11.536 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.093192e-12 | 11.510 | 1 | 1 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.671063e-12 | 11.435 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.668066e-12 | 11.436 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.668066e-12 | 11.436 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.947398e-12 | 11.404 | 1 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.944711e-12 | 11.306 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.944711e-12 | 11.306 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.178569e-12 | 11.087 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.042333e-11 | 10.982 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.042333e-11 | 10.982 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.111566e-11 | 10.954 | 1 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.248324e-11 | 10.904 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.320899e-11 | 10.879 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.434464e-11 | 10.843 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.636169e-11 | 10.786 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.824119e-11 | 10.739 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.824119e-11 | 10.739 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.777900e-11 | 10.750 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.087452e-11 | 10.680 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.087452e-11 | 10.680 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.087452e-11 | 10.680 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.951883e-11 | 10.710 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.604339e-11 | 10.584 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.604339e-11 | 10.584 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.996903e-11 | 10.398 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.996903e-11 | 10.398 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.918466e-11 | 10.308 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.117695e-11 | 10.291 | 1 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.247058e-11 | 10.204 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.941359e-11 | 10.049 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.664380e-11 | 10.062 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.664380e-11 | 10.062 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.306624e-10 | 9.884 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.529871e-10 | 9.815 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.658627e-10 | 9.780 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.562448e-10 | 9.806 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.843574e-10 | 9.734 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.059743e-10 | 9.686 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.248902e-10 | 9.648 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.420646e-10 | 9.616 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.484369e-10 | 9.605 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.677736e-10 | 9.572 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.662900e-10 | 9.575 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.750870e-10 | 9.561 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.921919e-10 | 9.534 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.369418e-10 | 9.472 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.762044e-10 | 9.425 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.439838e-10 | 9.353 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.179968e-10 | 9.144 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.384329e-10 | 9.077 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.269640e-09 | 8.896 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.436838e-09 | 8.843 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.695619e-09 | 8.771 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.909185e-09 | 8.719 | 1 | 1 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.326704e-09 | 8.633 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.182330e-09 | 8.661 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.669151e-09 | 8.574 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.056019e-09 | 8.515 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.983474e-09 | 8.400 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.535518e-09 | 8.343 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.658988e-09 | 8.332 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.620103e-09 | 8.335 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.658988e-09 | 8.332 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.658988e-09 | 8.332 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.154973e-09 | 8.288 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.459417e-09 | 8.073 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.789027e-09 | 8.056 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.026274e-08 | 7.989 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.063032e-08 | 7.973 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.073415e-08 | 7.969 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.353977e-08 | 7.868 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.297689e-08 | 7.887 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.362947e-08 | 7.866 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.517402e-08 | 7.819 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.118378e-08 | 7.674 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.037476e-08 | 7.517 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.366264e-08 | 7.473 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.633897e-08 | 7.440 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.414599e-08 | 7.355 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.879937e-08 | 7.312 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.972029e-08 | 7.303 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.609098e-08 | 7.251 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.754421e-08 | 7.240 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.417715e-08 | 7.193 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.548691e-08 | 7.184 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.155217e-08 | 7.145 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.717372e-08 | 7.060 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.763356e-08 | 7.057 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 9.211581e-08 | 7.036 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.274808e-07 | 6.895 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.636511e-07 | 6.786 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.116557e-07 | 6.674 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.116557e-07 | 6.674 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.217964e-07 | 6.654 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.441443e-07 | 6.463 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.605750e-07 | 6.443 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.387501e-07 | 6.358 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.475267e-07 | 6.189 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.937811e-07 | 6.159 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.309318e-07 | 6.080 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.589864e-07 | 6.066 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 9.182751e-07 | 6.037 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.388156e-07 | 6.027 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.062440e-06 | 5.974 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.281756e-06 | 5.892 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.307172e-06 | 5.884 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.307172e-06 | 5.884 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.307172e-06 | 5.884 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.373978e-06 | 5.862 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.373978e-06 | 5.862 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.549391e-06 | 5.810 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.999281e-06 | 5.699 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.856883e-06 | 5.544 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.856883e-06 | 5.544 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.858801e-06 | 5.414 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.851310e-06 | 5.414 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.843837e-06 | 5.415 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.583089e-06 | 5.339 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.874445e-06 | 5.412 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.860387e-06 | 5.313 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.523226e-06 | 5.258 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.344746e-06 | 5.198 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.764334e-06 | 5.170 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.764334e-06 | 5.170 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.406788e-06 | 5.130 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.516627e-06 | 5.070 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.821942e-06 | 5.054 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.821942e-06 | 5.054 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.043100e-06 | 5.044 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.373053e-06 | 5.028 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.605641e-06 | 5.017 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.174106e-05 | 4.930 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.339006e-05 | 4.873 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.457741e-05 | 4.836 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.498870e-05 | 4.824 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.521156e-05 | 4.818 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.834917e-05 | 4.736 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.467567e-05 | 4.608 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.570256e-05 | 4.590 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.650886e-05 | 4.577 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.810254e-05 | 4.551 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.028721e-05 | 4.519 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.553690e-05 | 4.449 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.241006e-05 | 4.489 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.069816e-05 | 4.513 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.891520e-05 | 4.539 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.557424e-05 | 4.449 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.572473e-05 | 4.447 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.785535e-05 | 4.422 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.494304e-05 | 4.347 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.266316e-05 | 4.278 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.526305e-05 | 4.258 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.526305e-05 | 4.258 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.526305e-05 | 4.258 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.526305e-05 | 4.258 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.559821e-05 | 4.255 | 1 | 1 |
| Signaling by VEGF | R-HSA-194138 | 5.731026e-05 | 4.242 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.910241e-05 | 4.228 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.972776e-05 | 4.224 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.379998e-05 | 4.195 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.392838e-05 | 4.194 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.718342e-05 | 4.173 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.421163e-05 | 4.130 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.090687e-05 | 4.041 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.090687e-05 | 4.041 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.160553e-05 | 4.038 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.123191e-04 | 3.950 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.278090e-04 | 3.893 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.403098e-04 | 3.853 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.416945e-04 | 3.849 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.508246e-04 | 3.822 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.523716e-04 | 3.817 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.589011e-04 | 3.799 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.779905e-04 | 3.750 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.807995e-04 | 3.743 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.880623e-04 | 3.726 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.880623e-04 | 3.726 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.880623e-04 | 3.726 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.924700e-04 | 3.716 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.017429e-04 | 3.695 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.107174e-04 | 3.676 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.797365e-04 | 3.553 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.603050e-04 | 3.585 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.847007e-04 | 3.546 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.576698e-04 | 3.589 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.654180e-04 | 3.576 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.797365e-04 | 3.553 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.868731e-04 | 3.542 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.902734e-04 | 3.537 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.926789e-04 | 3.534 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.439746e-04 | 3.463 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.661967e-04 | 3.436 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.351183e-04 | 3.361 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.372857e-04 | 3.359 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.523627e-04 | 3.345 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.329062e-04 | 3.273 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.530444e-04 | 3.257 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 5.534343e-04 | 3.257 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.828743e-04 | 3.234 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.010944e-04 | 3.221 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.501186e-04 | 3.125 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.020471e-04 | 3.045 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.159887e-04 | 3.038 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.828532e-04 | 3.008 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.847252e-04 | 3.007 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.056571e-03 | 2.976 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.132234e-03 | 2.946 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.154687e-03 | 2.938 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 1.194915e-03 | 2.923 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.221642e-03 | 2.913 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.295509e-03 | 2.888 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.340044e-03 | 2.873 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 1.406052e-03 | 2.852 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.606783e-03 | 2.794 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.639234e-03 | 2.785 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.753080e-03 | 2.756 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.151683e-03 | 2.667 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.183521e-03 | 2.661 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.368373e-03 | 2.626 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.398549e-03 | 2.620 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.430986e-03 | 2.614 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.776003e-03 | 2.557 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.811354e-03 | 2.551 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.811354e-03 | 2.551 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.829428e-03 | 2.548 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.044470e-03 | 2.516 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.192872e-03 | 2.496 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.270413e-03 | 2.485 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.484782e-03 | 2.458 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.293641e-03 | 2.367 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.357882e-03 | 2.361 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.572705e-03 | 2.340 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.869442e-03 | 2.313 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.341401e-03 | 2.272 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.337205e-03 | 2.198 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.604442e-03 | 2.180 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.929059e-03 | 2.101 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.929059e-03 | 2.101 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.929059e-03 | 2.101 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.362724e-03 | 2.029 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.460586e-03 | 2.024 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.611187e-03 | 2.180 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 9.362724e-03 | 2.029 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.604442e-03 | 2.180 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 7.929059e-03 | 2.101 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.604442e-03 | 2.180 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 9.362724e-03 | 2.029 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.137579e-03 | 2.090 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.923980e-03 | 2.160 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.821982e-03 | 2.008 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.482980e-03 | 2.023 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.651633e-03 | 2.116 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.905990e-03 | 2.004 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.036681e-02 | 1.984 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.090268e-02 | 1.962 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.090268e-02 | 1.962 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.096291e-02 | 1.960 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.136250e-02 | 1.945 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.191417e-02 | 1.924 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.191417e-02 | 1.924 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.191417e-02 | 1.924 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.191417e-02 | 1.924 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.191417e-02 | 1.924 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.191417e-02 | 1.924 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.219125e-02 | 1.914 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.220872e-02 | 1.913 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.220872e-02 | 1.913 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.220872e-02 | 1.913 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.254621e-02 | 1.901 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.254621e-02 | 1.901 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.254621e-02 | 1.901 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.306012e-02 | 1.884 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.360203e-02 | 1.866 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.436030e-02 | 1.843 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.503364e-02 | 1.823 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.522871e-02 | 1.817 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.541316e-02 | 1.812 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.541316e-02 | 1.812 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.542249e-02 | 1.812 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.591556e-02 | 1.798 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.613343e-02 | 1.792 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.613343e-02 | 1.792 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.648408e-02 | 1.783 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.807193e-02 | 1.743 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.859149e-02 | 1.731 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.873221e-02 | 1.727 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.920436e-02 | 1.717 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.010366e-02 | 1.697 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.010366e-02 | 1.697 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.093414e-02 | 1.679 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.093414e-02 | 1.679 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.154851e-02 | 1.667 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.216523e-02 | 1.654 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.222614e-02 | 1.653 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.282816e-02 | 1.642 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.412310e-02 | 1.618 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.443694e-02 | 1.612 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.479679e-02 | 1.606 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.548161e-02 | 1.594 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.673369e-02 | 1.573 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.911403e-02 | 1.536 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.911403e-02 | 1.536 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.975314e-02 | 1.526 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.975314e-02 | 1.526 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.024709e-02 | 1.519 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.045416e-02 | 1.516 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.046271e-02 | 1.516 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.046271e-02 | 1.516 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.312987e-02 | 1.480 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.315655e-02 | 1.479 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.382660e-02 | 1.471 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.392006e-02 | 1.470 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.411640e-02 | 1.467 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.411640e-02 | 1.467 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.419284e-02 | 1.466 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.532052e-02 | 1.452 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.620771e-02 | 1.441 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.632158e-02 | 1.440 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.673395e-02 | 1.435 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.673395e-02 | 1.435 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.673395e-02 | 1.435 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.787830e-02 | 1.422 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.852532e-02 | 1.414 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.942617e-02 | 1.404 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.942617e-02 | 1.404 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.965535e-02 | 1.402 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.681601e-02 | 1.330 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.681601e-02 | 1.330 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.681601e-02 | 1.330 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.681601e-02 | 1.330 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.681601e-02 | 1.330 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.681601e-02 | 1.330 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.681601e-02 | 1.330 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.681601e-02 | 1.330 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.681601e-02 | 1.330 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.681601e-02 | 1.330 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.681601e-02 | 1.330 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.939975e-02 | 1.159 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 8.049119e-02 | 1.094 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 8.049119e-02 | 1.094 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.502613e-02 | 1.347 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.502613e-02 | 1.347 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.703097e-02 | 1.244 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.937159e-02 | 1.307 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.605210e-02 | 1.251 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.030284e-02 | 1.095 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.319508e-02 | 1.199 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.079369e-02 | 1.150 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.319508e-02 | 1.199 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.649409e-02 | 1.248 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.681601e-02 | 1.330 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.817522e-02 | 1.235 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.018840e-02 | 1.220 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.007696e-02 | 1.154 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 8.049119e-02 | 1.094 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.393411e-02 | 1.268 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.393411e-02 | 1.268 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.202451e-02 | 1.207 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.000561e-02 | 1.155 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.939975e-02 | 1.159 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 8.049119e-02 | 1.094 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.947026e-02 | 1.226 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.682999e-02 | 1.329 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.857013e-02 | 1.105 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.614120e-02 | 1.118 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 8.049119e-02 | 1.094 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 8.049119e-02 | 1.094 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.067044e-02 | 1.295 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.939077e-02 | 1.159 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.242841e-02 | 1.140 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.338700e-02 | 1.134 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.681997e-02 | 1.115 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.080417e-02 | 1.389 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.669439e-02 | 1.115 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.018840e-02 | 1.220 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.331070e-02 | 1.273 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.000561e-02 | 1.155 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.965916e-02 | 1.304 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.454771e-02 | 1.128 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.219092e-02 | 1.375 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 4.974596e-02 | 1.303 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.089972e-02 | 1.293 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.089972e-02 | 1.293 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.018840e-02 | 1.220 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.393411e-02 | 1.268 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.000561e-02 | 1.155 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.466892e-02 | 1.350 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.558729e-02 | 1.341 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.681997e-02 | 1.115 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.145638e-02 | 1.289 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.383394e-02 | 1.077 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.383394e-02 | 1.077 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.741165e-02 | 1.058 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.741165e-02 | 1.058 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.741165e-02 | 1.058 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.766655e-02 | 1.057 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 9.145111e-02 | 1.039 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 9.145111e-02 | 1.039 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 9.145111e-02 | 1.039 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 9.145111e-02 | 1.039 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 9.145111e-02 | 1.039 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 9.145111e-02 | 1.039 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.021570e-01 | 0.991 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.021570e-01 | 0.991 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 1.021570e-01 | 0.991 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.022811e-01 | 0.990 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 1.022811e-01 | 0.990 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.022811e-01 | 0.990 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.049917e-01 | 0.979 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.059623e-01 | 0.975 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.069491e-01 | 0.971 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.136301e-01 | 0.945 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.172354e-01 | 0.931 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.172354e-01 | 0.931 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.175256e-01 | 0.930 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 1.235572e-01 | 0.908 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 1.235572e-01 | 0.908 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.235572e-01 | 0.908 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.235572e-01 | 0.908 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.235572e-01 | 0.908 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.254153e-01 | 0.902 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.254153e-01 | 0.902 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.254153e-01 | 0.902 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.294068e-01 | 0.888 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.334276e-01 | 0.875 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.334276e-01 | 0.875 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.334276e-01 | 0.875 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.340064e-01 | 0.873 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.340064e-01 | 0.873 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.340064e-01 | 0.873 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.340064e-01 | 0.873 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.340064e-01 | 0.873 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.340064e-01 | 0.873 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.340064e-01 | 0.873 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.374766e-01 | 0.862 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 1.443316e-01 | 0.841 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.443316e-01 | 0.841 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.443316e-01 | 0.841 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.443316e-01 | 0.841 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.443316e-01 | 0.841 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.443838e-01 | 0.840 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.465974e-01 | 0.834 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.479419e-01 | 0.830 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.487646e-01 | 0.828 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.487646e-01 | 0.828 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.487646e-01 | 0.828 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.522085e-01 | 0.818 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.539293e-01 | 0.813 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.545344e-01 | 0.811 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 1.545344e-01 | 0.811 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.545344e-01 | 0.811 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.554255e-01 | 0.808 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.573207e-01 | 0.803 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.622080e-01 | 0.790 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.636303e-01 | 0.786 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.646161e-01 | 0.784 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.646161e-01 | 0.784 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.646161e-01 | 0.784 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.646161e-01 | 0.784 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.646161e-01 | 0.784 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.723602e-01 | 0.764 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.723602e-01 | 0.764 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.745783e-01 | 0.758 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 1.745783e-01 | 0.758 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.745783e-01 | 0.758 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.745783e-01 | 0.758 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.745783e-01 | 0.758 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.745783e-01 | 0.758 | 0 | 0 |
| Translation | R-HSA-72766 | 1.748019e-01 | 0.757 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.760758e-01 | 0.754 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.792539e-01 | 0.747 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.792539e-01 | 0.747 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.844222e-01 | 0.734 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.844222e-01 | 0.734 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.844222e-01 | 0.734 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.844222e-01 | 0.734 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.844222e-01 | 0.734 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.844222e-01 | 0.734 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.868447e-01 | 0.729 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.941494e-01 | 0.712 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.941494e-01 | 0.712 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 1.941494e-01 | 0.712 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.941494e-01 | 0.712 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.941494e-01 | 0.712 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.941494e-01 | 0.712 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.964688e-01 | 0.707 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.971097e-01 | 0.705 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.008051e-01 | 0.697 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.037611e-01 | 0.691 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.037611e-01 | 0.691 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.037611e-01 | 0.691 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.037611e-01 | 0.691 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.037611e-01 | 0.691 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 2.037611e-01 | 0.691 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.084862e-01 | 0.681 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.095105e-01 | 0.679 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.095105e-01 | 0.679 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.095105e-01 | 0.679 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.132588e-01 | 0.671 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.132588e-01 | 0.671 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.132588e-01 | 0.671 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.226437e-01 | 0.652 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.226437e-01 | 0.652 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.226437e-01 | 0.652 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.302877e-01 | 0.638 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.308958e-01 | 0.637 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.314253e-01 | 0.636 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.319173e-01 | 0.635 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.319173e-01 | 0.635 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 2.319173e-01 | 0.635 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.319173e-01 | 0.635 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.402349e-01 | 0.619 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 2.410808e-01 | 0.618 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.410808e-01 | 0.618 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.410808e-01 | 0.618 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.410808e-01 | 0.618 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.446461e-01 | 0.611 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 2.446461e-01 | 0.611 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 2.501356e-01 | 0.602 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.501356e-01 | 0.602 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.590828e-01 | 0.587 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.679239e-01 | 0.572 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.679239e-01 | 0.572 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.679239e-01 | 0.572 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 2.679239e-01 | 0.572 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.679239e-01 | 0.572 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.711575e-01 | 0.567 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.755773e-01 | 0.560 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.755773e-01 | 0.560 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.755773e-01 | 0.560 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.766600e-01 | 0.558 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.766600e-01 | 0.558 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.766600e-01 | 0.558 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.766600e-01 | 0.558 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.766600e-01 | 0.558 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.767509e-01 | 0.558 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.767509e-01 | 0.558 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.799958e-01 | 0.553 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.799958e-01 | 0.553 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.844124e-01 | 0.546 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.852924e-01 | 0.545 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 2.852924e-01 | 0.545 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.852924e-01 | 0.545 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.852924e-01 | 0.545 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.938223e-01 | 0.532 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.938223e-01 | 0.532 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.938223e-01 | 0.532 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 2.938223e-01 | 0.532 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.938223e-01 | 0.532 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.938223e-01 | 0.532 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 2.976451e-01 | 0.526 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 3.022509e-01 | 0.520 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.022509e-01 | 0.520 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 3.022509e-01 | 0.520 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.041892e-01 | 0.517 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.105794e-01 | 0.508 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.105794e-01 | 0.508 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.105794e-01 | 0.508 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 3.105794e-01 | 0.508 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.105794e-01 | 0.508 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.105794e-01 | 0.508 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.108406e-01 | 0.507 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.188090e-01 | 0.496 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.196101e-01 | 0.495 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.237435e-01 | 0.490 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.269409e-01 | 0.486 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.269409e-01 | 0.486 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.269409e-01 | 0.486 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 3.269409e-01 | 0.486 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 3.269409e-01 | 0.486 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.349762e-01 | 0.475 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.349762e-01 | 0.475 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.349762e-01 | 0.475 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.349762e-01 | 0.475 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.349762e-01 | 0.475 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.349762e-01 | 0.475 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.400460e-01 | 0.468 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.429161e-01 | 0.465 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 3.429161e-01 | 0.465 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.429161e-01 | 0.465 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.429161e-01 | 0.465 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.429161e-01 | 0.465 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.438190e-01 | 0.464 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.507617e-01 | 0.455 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.507617e-01 | 0.455 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.507617e-01 | 0.455 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.507617e-01 | 0.455 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.507617e-01 | 0.455 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.585140e-01 | 0.445 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.585140e-01 | 0.445 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 3.585140e-01 | 0.445 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.585140e-01 | 0.445 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.586935e-01 | 0.445 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.595747e-01 | 0.444 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.661743e-01 | 0.436 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 3.708742e-01 | 0.431 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.715486e-01 | 0.430 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.737436e-01 | 0.427 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.737436e-01 | 0.427 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.737436e-01 | 0.427 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.737436e-01 | 0.427 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.737436e-01 | 0.427 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.737436e-01 | 0.427 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.737436e-01 | 0.427 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.812229e-01 | 0.419 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.812229e-01 | 0.419 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 3.812229e-01 | 0.419 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.886134e-01 | 0.410 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.886134e-01 | 0.410 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.959160e-01 | 0.402 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.031319e-01 | 0.395 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.031319e-01 | 0.395 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.031319e-01 | 0.395 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.031319e-01 | 0.395 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.031319e-01 | 0.395 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.102620e-01 | 0.387 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.136073e-01 | 0.383 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.173074e-01 | 0.380 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.218553e-01 | 0.375 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.242690e-01 | 0.372 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.242690e-01 | 0.372 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.242690e-01 | 0.372 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.242690e-01 | 0.372 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.242690e-01 | 0.372 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.311479e-01 | 0.365 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.311479e-01 | 0.365 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.311479e-01 | 0.365 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.311479e-01 | 0.365 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.311479e-01 | 0.365 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.311479e-01 | 0.365 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.311479e-01 | 0.365 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.311479e-01 | 0.365 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 4.379451e-01 | 0.359 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.381710e-01 | 0.358 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 4.389251e-01 | 0.358 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.446614e-01 | 0.352 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.512978e-01 | 0.346 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.512978e-01 | 0.346 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.538110e-01 | 0.343 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.578554e-01 | 0.339 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.582102e-01 | 0.339 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.643350e-01 | 0.333 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 4.643350e-01 | 0.333 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.643350e-01 | 0.333 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.643350e-01 | 0.333 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.643350e-01 | 0.333 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.643350e-01 | 0.333 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.707376e-01 | 0.327 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.707376e-01 | 0.327 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.770640e-01 | 0.321 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.770640e-01 | 0.321 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.770640e-01 | 0.321 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.770640e-01 | 0.321 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 4.833152e-01 | 0.316 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.894920e-01 | 0.310 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.894920e-01 | 0.310 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.955954e-01 | 0.305 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.955954e-01 | 0.305 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 4.978461e-01 | 0.303 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 5.045679e-01 | 0.297 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 5.075853e-01 | 0.294 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 5.075853e-01 | 0.294 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 5.076318e-01 | 0.294 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.134734e-01 | 0.289 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.134734e-01 | 0.289 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.134734e-01 | 0.289 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.134734e-01 | 0.289 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.192915e-01 | 0.285 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.192915e-01 | 0.285 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 5.192915e-01 | 0.285 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.192915e-01 | 0.285 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.250404e-01 | 0.280 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.304070e-01 | 0.275 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.338979e-01 | 0.273 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.363338e-01 | 0.271 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.363338e-01 | 0.271 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.482982e-01 | 0.261 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.527749e-01 | 0.257 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.581254e-01 | 0.253 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.634121e-01 | 0.249 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.634121e-01 | 0.249 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.634121e-01 | 0.249 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.686360e-01 | 0.245 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.686360e-01 | 0.245 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.686360e-01 | 0.245 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.725385e-01 | 0.242 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.737976e-01 | 0.241 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.788978e-01 | 0.237 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.788978e-01 | 0.237 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.859628e-01 | 0.232 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.938370e-01 | 0.226 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.938370e-01 | 0.226 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.986986e-01 | 0.223 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.986986e-01 | 0.223 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.990749e-01 | 0.223 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.082488e-01 | 0.216 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 6.082488e-01 | 0.216 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.082488e-01 | 0.216 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.129388e-01 | 0.213 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.129388e-01 | 0.213 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.175729e-01 | 0.209 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.175729e-01 | 0.209 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.212689e-01 | 0.207 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.221518e-01 | 0.206 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.221518e-01 | 0.206 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.221518e-01 | 0.206 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.266762e-01 | 0.203 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 6.303135e-01 | 0.200 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.304882e-01 | 0.200 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.355639e-01 | 0.197 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.442410e-01 | 0.191 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.527127e-01 | 0.185 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.527127e-01 | 0.185 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 6.568729e-01 | 0.183 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.568729e-01 | 0.183 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.609836e-01 | 0.180 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.690585e-01 | 0.175 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.712168e-01 | 0.173 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.712168e-01 | 0.173 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.769420e-01 | 0.169 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.769420e-01 | 0.169 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.769420e-01 | 0.169 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 6.848604e-01 | 0.164 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.958431e-01 | 0.157 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.958431e-01 | 0.157 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.994891e-01 | 0.155 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 7.101685e-01 | 0.149 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.132513e-01 | 0.147 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.136437e-01 | 0.147 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.136437e-01 | 0.147 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.238225e-01 | 0.140 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.304076e-01 | 0.136 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.304076e-01 | 0.136 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.368365e-01 | 0.133 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.492402e-01 | 0.125 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.552222e-01 | 0.122 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.610622e-01 | 0.119 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.695633e-01 | 0.114 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.750629e-01 | 0.111 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.799785e-01 | 0.108 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.830683e-01 | 0.106 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.882472e-01 | 0.103 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.933030e-01 | 0.101 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.957857e-01 | 0.099 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 8.008297e-01 | 0.096 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 8.030572e-01 | 0.095 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.077612e-01 | 0.093 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.100711e-01 | 0.091 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.107051e-01 | 0.091 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.146084e-01 | 0.089 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.212129e-01 | 0.086 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.254854e-01 | 0.083 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.296562e-01 | 0.081 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 8.409332e-01 | 0.075 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.415831e-01 | 0.075 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.472311e-01 | 0.072 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 8.562028e-01 | 0.067 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.630012e-01 | 0.064 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.646502e-01 | 0.063 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.646502e-01 | 0.063 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.694798e-01 | 0.061 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.710512e-01 | 0.060 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.815366e-01 | 0.055 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.928658e-01 | 0.049 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.988101e-01 | 0.046 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.988101e-01 | 0.046 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.156490e-01 | 0.038 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.192572e-01 | 0.037 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.313859e-01 | 0.031 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.346420e-01 | 0.029 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.500001e-01 | 0.022 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.511909e-01 | 0.022 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.546298e-01 | 0.020 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.638410e-01 | 0.016 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.653822e-01 | 0.015 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.653822e-01 | 0.015 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.677492e-01 | 0.014 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.728151e-01 | 0.012 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.779137e-01 | 0.010 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.816268e-01 | 0.008 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.935206e-01 | 0.003 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.937554e-01 | 0.003 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.986834e-01 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.994204e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996069e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999771e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999914e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999996e-01 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
